Pain	O
relief	O
that	O
matters	O
to	O
patients	O
:	O
systematic	O
review	O
of	O
empirical	O
studies	O
assessing	O
the	O
minimum	O
clinically	O
important	O
difference	O
in	O
acute	O
pain	O

Background	O

The	O
minimum	O
clinically	O
important	O
difference	O
(	O
MCID	O
)	O
is	O
used	O
to	O
interpret	O
the	O
clinical	O
relevance	O
of	O
results	O
reported	O
by	O
trials	O
and	O
meta	O
-	O
analyses	O
as	O
well	O
as	O
to	O
plan	O
sample	O
sizes	O
in	O
new	O
studies	O
.	O

However	O
,	O
there	O
is	O
a	O
lack	O
of	O
consensus	O
about	O
the	O
size	O
of	O
MCID	O
in	O
acute	O
pain	O
,	O
which	O
is	O
a	O
core	O
symptom	O
affecting	O
patients	O
across	O
many	O
clinical	O
conditions	O
.	O

Methods	O

We	O
identified	O
and	O
systematically	O
reviewed	O
empirical	O
studies	O
of	O
MCID	O
in	O
acute	O
pain	O
.	O

We	O
searched	O
PubMed	O
,	O
EMBASE	O
and	O
Cochrane	O
Library	O
,	O
and	O
included	O
prospective	O
studies	O
determining	O
MCID	O
using	O
a	O
patient	O
-	O
reported	O
anchor	O
and	O
a	O
one	O
-	O
dimensional	O
pain	O
scale	O
(	O
e	O
.	O
g	O
.	O
100	O
mm	O
visual	O
analogue	O
scale	O
).	O

We	O
summarised	O
results	O
and	O
explored	O
reasons	O
for	O
heterogeneity	O
applying	O
meta	O
-	O
regression	O
,	O
subgroup	O
analyses	O
and	O
individual	O
patient	O
data	O
meta	O
-	O
analyses	O
.	O

Results	O

We	O
included	O
37	O
studies	O
(	O
8479	O
patients	O
).	O

Thirty	O
-	O
five	O
studies	O
used	O
a	O
mean	O
change	O
approach	O
,	O
i	O
.	O
e	O
.	O
MCID	O
was	O
assessed	O
as	O
the	O
mean	O
difference	O
in	O
pain	O
score	O
among	O
patients	O
who	O
reported	O
a	O
minimum	O
degree	O
of	O
improvement	O
,	O
while	O
seven	O
studies	O
used	O
a	O
threshold	O
approach	O
,	O
i	O
.	O
e	O
.	O
MCID	O
was	O
assessed	O
as	O
the	O
threshold	O
in	O
pain	O
reduction	O
associated	O
with	O
the	O
best	O
accuracy	O
(	O
sensitivity	O
and	O
specificity	O
)	O
for	O
identifying	O
improved	O
patients	O
.	O

Meta	O
-	O
analyses	O
found	O
considerable	O
heterogeneity	O
between	O
studies	O
(	O
absolute	O
MCID	O
:	O
I2	O
=	O
93	O
%,	O
relative	O
MCID	O
:	O
I2	O
=	O
75	O
%)	O
and	O
results	O
were	O
therefore	O
presented	O
qualitatively	O
,	O
while	O
analyses	O
focused	O
on	O
exploring	O
reasons	O
for	O
heterogeneity	O
.	O

The	O
reported	O
absolute	O
MCID	O
values	O
ranged	O
widely	O
from	O
8	O
to	O
40	O
mm	O
(	O
standardised	O
to	O
a	O
100	O
mm	O
scale	O
)	O
and	O
the	O
relative	O
MCID	O
values	O
from	O
13	O
%	O
to	O
85	O
%.	O

From	O
analyses	O
of	O
individual	O
patient	O
data	O
(	O
seven	O
studies	O
,	O
918	O
patients	O
),	O
we	O
found	O
baseline	O
pain	O
strongly	O
associated	O
with	O
absolute	O
,	O
but	O
not	O
relative	O
,	O
MCID	O
as	O
patients	O
with	O
higher	O
baseline	O
pain	O
needed	O
larger	O
pain	O
reduction	O
to	O
perceive	O
relief	O
.	O

Subgroup	O
analyses	O
showed	O
that	O
the	O
definition	O
of	O
improved	O
patients	O
(	O
one	O
or	O
several	O
categories	O
improvement	O
or	O
meaningful	O
change	O
)	O
and	O
the	O
design	O
of	O
studies	O
(	O
single	O
or	O
multiple	O
measurements	O
)	O
also	O
influenced	O
MCID	O
values	O
.	O

Conclusions	O

The	O
MCID	O
in	O
acute	O
pain	O
varied	O
greatly	O
between	O
studies	O
and	O
was	O
influenced	O
by	O
baseline	O
pain	O
,	O
definitions	O
of	O
improved	O
patients	O
and	O
study	O
design	O
.	O

MCID	O
is	O
context	O
-	O
specific	O
and	O
potentially	O
misguiding	O
if	O
determined	O
,	O
applied	O
or	O
interpreted	O
inappropriately	O
.	O

Explicit	O
and	O
conscientious	O
reflections	O
on	O
the	O
choice	O
of	O
a	O
reference	O
value	O
are	O
required	O
when	O
using	O
MCID	O
to	O
classify	O
research	O
results	O
as	O
clinically	O
important	O
or	O
trivial	O
.	O

Background	O

It	O
can	O
be	O
challenging	O
to	O
decide	O
whether	O
a	O
modest	O
effect	O
in	O
a	O
randomised	O
clinical	O
trial	O
,	O
or	O
a	O
meta	O
-	O
analysis	O
of	O
several	O
such	O
trials	O
,	O
is	O
clinically	O
relevant	O
.	O

Statistical	O
tests	O
inform	O
on	O
the	O
probability	O
of	O
a	O
result	O
being	O
a	O
chance	O
finding	O
;	O
however	O
,	O
they	O
convey	O
no	O
information	O
on	O
whether	O
a	O
given	O
effect	O
will	O
be	O
experienced	O
as	O
important	O
by	O
patients	O
.	O

The	O
degree	O
of	O
pain	O
reduction	O
that	O
is	O
considered	O
clinically	O
relevant	O
has	O
an	O
impact	O
on	O
which	O
analgesic	O
interventions	O
are	O
regarded	O
clinically	O
useful	O
.	O

This	O
interpretation	O
problem	O
for	O
clinical	O
relevance	O
has	O
been	O
at	O
the	O
core	O
of	O
debates	O
of	O
the	O
importance	O
of	O
several	O
types	O
of	O
interventions	O
intended	O
for	O
reducing	O
acute	O
pain	O
,	O
for	O
example	O
,	O
paracetamol	O
[	O
1	O
–	O
3	O
],	O
non	O
-	O
steroidal	O
anti	O
-	O
inflammatory	O
drugs	O
[	O
4	O
,	O
5	O
],	O
morphine	O
or	O
synthetic	O
opiates	O
[	O
6	O
],	O
corticosteroids	O
[	O
7	O
],	O
muscle	O
relaxants	O
[	O
4	O
],	O
laser	O
therapy	O
[	O
8	O
],	O
transcranial	O
direct	O
current	O
stimulation	O
[	O
9	O
],	O
EMLA	O
cream	O
[	O
10	O
],	O
and	O
acupuncture	O
[	O
11	O
].	O

A	O
related	O
challenge	O
involves	O
the	O
calculation	O
of	O
sample	O
sizes	O
for	O
clinical	O
trials	O
,	O
where	O
researchers	O
need	O
to	O
know	O
the	O
smallest	O
clinically	O
important	O
effect	O
that	O
the	O
trial	O
should	O
not	O
miss	O
to	O
be	O
able	O
to	O
determine	O
an	O
adequate	O
sample	O
size	O
.	O

Jaeschke	O
et	O
al	O
.	O
[	O
12	O
]	O
characterised	O
the	O
concept	O
of	O
minimum	O
clinically	O
relevant	O
difference	O
in	O
1989	O
as	O
“	O
the	O
smallest	O
difference	O
in	O
score	O
in	O
the	O
domain	O
of	O
interest	O
which	O
participants	O
perceive	O
as	O
beneficial	O
and	O
which	O
would	O
mandate	O
,	O
in	O
the	O
absence	O
of	O
troublesome	O
side	O
effects	O
and	O
costs	O
,	O
a	O
change	O
in	O
the	O
patient	O
’	O
s	O
management	O
”.	O

The	O
strength	O
of	O
the	O
concept	O
is	O
that	O
it	O
defines	O
a	O
relevant	O
effect	O
size	O
based	O
on	O
clinical	O
considerations	O
and	O
not	O
only	O
statistical	O
significance	O
[	O
13	O
,	O
14	O
].	O

It	O
has	O
subsequently	O
been	O
supplemented	O
by	O
a	O
related	O
concept	O
–	O
the	O
substantial	O
(	O
and	O
not	O
only	O
minimum	O
)	O
clinically	O
relevant	O
difference	O
[	O
15	O
].	O

The	O
minimum	O
clinically	O
important	O
difference	O
(	O
MCID	O
)	O
is	O
sometimes	O
chosen	O
on	O
the	O
basis	O
of	O
expert	O
consensus	O
judgement	O
[	O
16	O
],	O
statistical	O
models	O
[	O
17	O
]	O
or	O
objective	O
criteria	O
[	O
18	O
].	O

However	O
,	O
in	O
acute	O
pain	O
,	O
it	O
seems	O
reasonable	O
to	O
anchor	O
clinical	O
relevance	O
to	O
the	O
patients	O
’	O
experience	O
.	O

This	O
approach	O
is	O
in	O
accordance	O
with	O
the	O
increasing	O
awareness	O
of	O
the	O
relevance	O
of	O
patient	O
-	O
reported	O
outcomes	O
in	O
clinical	O
research	O
[	O
19	O
].	O

Several	O
such	O
empirical	O
studies	O
have	O
been	O
conducted	O
to	O
determine	O
the	O
MCID	O
in	O
acute	O
pain	O
,	O
but	O
they	O
differ	O
with	O
regard	O
to	O
methodology	O
,	O
clinical	O
condition	O
and	O
findings	O
,	O
and	O
have	O
not	O
yet	O
been	O
systematically	O
reviewed	O
.	O

Since	O
acute	O
pain	O
is	O
a	O
core	O
symptom	O
in	O
healthcare	O
,	O
an	O
assessment	O
of	O
the	O
MCID	O
and	O
a	O
clarification	O
of	O
the	O
causes	O
for	O
its	O
variation	O
will	O
have	O
broad	O
interest	O
.	O

It	O
has	O
been	O
suggested	O
that	O
baseline	O
pain	O
influences	O
absolute	O
values	O
of	O
MCID	O
,	O
but	O
study	O
reports	O
have	O
been	O
conflicting	O
[	O
20	O
,	O
21	O
],	O
and	O
it	O
remains	O
unclear	O
which	O
other	O
clinical	O
or	O
methodological	O
factors	O
are	O
of	O
importance	O
.	O

We	O
therefore	O
decided	O
to	O
systematically	O
review	O
empirical	O
studies	O
of	O
the	O
MCID	O
in	O
acute	O
pain	O
relief	O
and	O
to	O
examine	O
possible	O
causes	O
for	O
variation	O
between	O
study	O
results	O
,	O
especially	O
their	O
likely	O
dependency	O
on	O
baseline	O
pain	O
levels	O
.	O

We	O
also	O
reviewed	O
studies	O
of	O
the	O
substantial	O
clinically	O
important	O
difference	O
in	O
acute	O
pain	O
relief	O
as	O
well	O
as	O
clinically	O
important	O
differences	O
for	O
worsening	O
of	O
pain	O
.	O

Methods	O

Eligibility	O
criteria	O

We	O
included	O
prospective	O
studies	O
of	O
patients	O
with	O
acute	O
pain	O
,	O
regardless	O
of	O
age	O
,	O
clinical	O
condition	O
,	O
and	O
intervention	O
,	O
in	O
which	O
pain	O
intensity	O
was	O
assessed	O
on	O
a	O
one	O
-	O
dimensional	O
scale	O
,	O
e	O
.	O
g	O
.	O
a	O
100	O
mm	O
visual	O
analogue	O
scale	O
(	O
VAS	O
)	O
or	O
a	O
0	O
–	O
10	O
point	O
numerical	O
rating	O
scale	O
(	O
NRS	O
),	O
and	O
in	O
which	O
the	O
MCID	O
was	O
determined	O
using	O
an	O
anchor	O
-	O
based	O
method	O
using	O
patients	O
’	O
perception	O
of	O
change	O
to	O
determine	O
clinical	O
importance	O
.	O

Pain	O
was	O
considered	O
acute	O
when	O
its	O
duration	O
was	O
less	O
than	O
1	O
month	O
or	O
,	O
if	O
duration	O
was	O
not	O
indicated	O
,	O
when	O
it	O
was	O
described	O
as	O
such	O
in	O
a	O
study	O
report	O
.	O

Studies	O
were	O
excluded	O
if	O
they	O
were	O
not	O
clinical	O
(	O
i	O
.	O
e	O
.	O
used	O
healthy	O
volunteers	O
)	O
or	O
determined	O
the	O
MCID	O
from	O
objective	O
criteria	O
(	O
e	O
.	O
g	O
.	O
return	O
to	O
work	O
),	O
the	O
distribution	O
of	O
data	O
(	O
e	O
.	O
g	O
.	O
the	O
minimum	O
detectable	O
difference	O
)	O
or	O
expert	O
consensus	O
.	O

A	O
typical	O
eligible	O
study	O
would	O
ask	O
patients	O
to	O
score	O
their	O
pain	O
intensity	O
,	O
e	O
.	O
g	O
.	O
using	O
a	O
VAS	O
,	O
at	O
baseline	O
and	O
follow	O
-	O
up	O
.	O

At	O
follow	O
-	O
up	O
,	O
patients	O
were	O
also	O
asked	O
to	O
categorise	O
their	O
change	O
in	O
pain	O
intensity	O
using	O
response	O
options	O
such	O
as	O
‘	O
no	O
change	O
’,	O
‘	O
a	O
little	O
better	O
’/‘	O
somewhat	O
better	O
’,	O
and	O
‘	O
a	O
lot	O
better	O
’/‘	O
much	O
better	O
’.	O

The	O
MCID	O
was	O
then	O
determined	O
from	O
the	O
change	O
in	O
scores	O
on	O
the	O
pain	O
scale	O
among	O
patients	O
having	O
categorised	O
their	O
change	O
as	O
‘	O
a	O
little	O
better	O
’	O
(	O
or	O
a	O
similar	O
expression	O
indicating	O
a	O
minimum	O
clinically	O
important	O
improvement	O
).	O

We	O
included	O
studies	O
with	O
two	O
types	O
of	O
analytical	O
approaches	O
(	O
1	O
)	O
the	O
‘	O
mean	O
change	O
approach	O
’,	O
i	O
.	O
e	O
.	O
the	O
mean	O
difference	O
in	O
pain	O
scores	O
among	O
patients	O
who	O
reported	O
a	O
minimum	O
degree	O
of	O
pain	O
relief	O
[	O
22	O
];	O
or	O
(	O
2	O
)	O
the	O
‘	O
threshold	O
approach	O
’,	O
i	O
.	O
e	O
.	O
the	O
threshold	O
value	O
for	O
pain	O
score	O
change	O
which	O
most	O
accurately	O
(	O
yield	O
﻿	O
i	O
﻿	O
ng	O
best	O
sensitivity	O
and	O
specificity	O
)	O
identified	O
patients	O
experiencing	O
relevant	O
pain	O
relief	O
in	O
analogy	O
with	O
a	O
diagnostic	O
test	O
where	O
the	O
gold	O
standard	O
is	O
patients	O
’	O
perception	O
of	O
change	O
[	O
23	O
].	O

Search	O
strategy	O

We	O
searched	O
PubMed	O
,	O
EMBASE	O
and	O
Cochrane	O
Library	O
until	O
August	O
2016	O
with	O
no	O
language	O
restrictions	O
.	O

The	O
core	O
search	O
string	O
was	O
:	O
(	O
minimal	O
OR	O
minimally	O
OR	O
minimum	O
OR	O
‘	O
clinically	O
significant	O
’	O
OR	O
‘	O
clinically	O
important	O
’	O
OR	O
‘	O
clinically	O
meaningful	O
’	O
OR	O
‘	O
clinically	O
relevant	O
’)	O
AND	O
(	O
difference	O
OR	O
change	O
OR	O
relief	O
OR	O
reduction	O
)	O
AND	O
(‘	O
pain	O
measurement	O
*’	O
OR	O
‘	O
visual	O
analog	O
scale	O
’	O
OR	O
‘	O
numeric	O
rating	O
scale	O
’)	O
AND	O
(	O
pain	O
)	O
with	O
variations	O
according	O
to	O
the	O
specific	O
database	O
(	O
Appendix	O
1	O
).	O

The	O
reference	O
lists	O
of	O
all	O
included	O
studies	O
and	O
relevant	O
review	O
papers	O
were	O
read	O
systematically	O
to	O
identify	O
further	O
studies	O
.	O

Screening	O
of	O
titles	O
and	O
abstracts	O
to	O
determine	O
the	O
eligibility	O
of	O
studies	O
was	O
done	O
by	O
the	O
primary	O
author	O
(	O
MFO	O
),	O
while	O
the	O
selected	O
full	O
-	O
text	O
records	O
were	O
examined	O
by	O
two	O
researchers	O
independently	O
(	O
MFO	O
and	O
either	O
EB	O
,	O
NEL	O
,	O
BT	O
,	O
or	O
MDH	O
).	O

Any	O
disagreement	O
was	O
solved	O
by	O
discussion	O
.	O

Data	O
extraction	O
and	O
retrieval	O

Data	O
extraction	O
was	O
conducted	O
by	O
two	O
researchers	O
independently	O
(	O
MFO	O
and	O
EB	O
,	O
BT	O
,	O
or	O
NEL	O
)	O
using	O
pretested	O
data	O
extraction	O
forms	O
generated	O
in	O
EpiData	O
(	O
EpiData	O
Association	O
,	O
Odense	O
,	O
Denmark	O
).	O

Any	O
disagreements	O
were	O
solved	O
by	O
discussion	O
.	O

For	O
each	O
study	O
,	O
we	O
extracted	O
descriptive	O
data	O
including	O
publication	O
year	O
,	O
study	O
design	O
,	O
setting	O
,	O
clinical	O
condition	O
,	O
type	O
of	O
intervention	O
,	O
sampling	O
method	O
,	O
sample	O
size	O
,	O
and	O
definition	O
of	O
patients	O
with	O
relevant	O
change	O
(	O
see	O
Appendix	O
2	O
for	O
complete	O
list	O
).	O

For	O
studies	O
using	O
a	O
mean	O
change	O
approach	O
,	O
we	O
extracted	O
the	O
following	O
outcome	O
data	O
:	O
the	O
MCID	O
for	O
pain	O
relief	O
(	O
absolute	O
values	O
in	O
mm	O
or	O
points	O
and	O
relative	O
value	O
in	O
percent	O
change	O
from	O
baseline	O
)	O
and	O
for	O
pain	O
worsening	O
(	O
absolute	O
and	O
relative	O
values	O
),	O
as	O
well	O
as	O
the	O
substantial	O
clinically	O
important	O
difference	O
for	O
relief	O
and	O
worsening	O
of	O
pain	O
(	O
absolute	O
and	O
relative	O
values	O
).	O

We	O
extracted	O
MCIDs	O
as	O
the	O
mean	O
change	O
in	O
pain	O
score	O
among	O
patients	O
who	O
indicated	O
a	O
one	O
-	O
category	O
improvement	O
(	O
e	O
.	O
g	O
.	O
‘	O
a	O
little	O
better	O
’).	O

If	O
unavailable	O
,	O
we	O
extracted	O
the	O
mean	O
change	O
among	O
patients	O
who	O
were	O
minimally	O
improved	O
by	O
authors	O
’	O
definition	O
(	O
e	O
.	O
g	O
.	O
some	O
authors	O
defined	O
minimum	O
important	O
change	O
as	O
the	O
mean	O
change	O
in	O
pain	O
score	O
among	O
patients	O
with	O
either	O
a	O
one	O
-	O
or	O
two	O
-	O
category	O
improvement	O
).	O

Similarly	O
,	O
we	O
extracted	O
the	O
substantial	O
clinically	O
important	O
differences	O
as	O
the	O
mean	O
change	O
among	O
patients	O
with	O
a	O
two	O
-	O
category	O
improvement	O
or	O
used	O
the	O
authors	O
’	O
definition	O
.	O

We	O
extracted	O
the	O
point	O
estimate	O
of	O
outcomes	O
with	O
their	O
corresponding	O
standard	O
error	O
or	O
,	O
if	O
unavailable	O
,	O
other	O
measures	O
of	O
variation	O
such	O
as	O
standard	O
deviation	O
or	O
95	O
%	O
confidence	O
interval	O
.	O

For	O
studies	O
using	O
a	O
threshold	O
approach	O
,	O
we	O
extracted	O
information	O
about	O
definition	O
of	O
responders	O
(	O
i	O
.	O
e	O
.	O
patients	O
with	O
relevant	O
change	O
)	O
and	O
non	O
-	O
responders	O
and	O
the	O
cut	O
-	O
off	O
point	O
with	O
its	O
corresponding	O
sensitivity	O
(	O
i	O
.	O
e	O
.	O
percentage	O
of	O
responders	O
correctly	O
classified	O
as	O
such	O
)	O
and	O
specificity	O
(	O
i	O
.	O
e	O
.	O
percentage	O
of	O
non	O
-	O
responders	O
correctly	O
classified	O
as	O
such	O
).	O

If	O
studies	O
reported	O
pain	O
scores	O
from	O
several	O
concurrent	O
pain	O
assessments	O
(	O
e	O
.	O
g	O
.	O
back	O
pain	O
and	O
leg	O
pain	O
),	O
we	O
extracted	O
the	O
assessment	O
where	O
more	O
data	O
were	O
available	O
or	O
,	O
if	O
no	O
difference	O
found	O
,	O
we	O
randomly	O
selected	O
which	O
to	O
extract	O
.	O

All	O
scales	O
were	O
standardised	O
to	O
a	O
0	O
–	O
100	O
mm	O
scale	O
.	O

When	O
studies	O
reported	O
pain	O
assessments	O
based	O
on	O
both	O
VAS	O
and	O
NRS	O
,	O
we	O
used	O
the	O
assessment	O
based	O
on	O
VAS	O
.	O

If	O
the	O
primary	O
outcome	O
or	O
other	O
key	O
variables	O
were	O
unclear	O
or	O
incompletely	O
reported	O
from	O
a	O
study	O
,	O
we	O
contacted	O
the	O
corresponding	O
author	O
.	O

In	O
cases	O
where	O
authors	O
provided	O
individual	O
patient	O
data	O
,	O
we	O
first	O
checked	O
whether	O
we	O
could	O
replicate	O
a	O
main	O
result	O
of	O
the	O
published	O
paper	O
.	O

We	O
then	O
calculated	O
estimates	O
of	O
absolute	O
and	O
relative	O
MCIDs	O
and	O
their	O
corresponding	O
standard	O
error	O
.	O

For	O
each	O
study	O
,	O
we	O
assessed	O
risk	O
of	O
attrition	O
bias	O
(	O
studies	O
were	O
considered	O
low	O
risk	O
when	O
attrition	O
<	O
10	O
%)	O
and	O
risk	O
of	O
non	O
-	O
representative	O
study	O
sample	O
(	O
studies	O
were	O
considered	O
low	O
risk	O
if	O
using	O
consecutive	O
or	O
random	O
sampling	O
).	O

Data	O
synthesis	O
and	O
analysis	O

For	O
each	O
study	O
,	O
we	O
extracted	O
or	O
calculated	O
the	O
MCID	O
for	O
pain	O
relief	O
(	O
absolute	O
and	O
relative	O
change	O
),	O
and	O
noted	O
results	O
of	O
any	O
study	O
-	O
based	O
exploration	O
of	O
causes	O
for	O
variation	O
,	O
e	O
.	O
g	O
.	O
baseline	O
pain	O
.	O

We	O
then	O
summarised	O
results	O
qualitatively	O
as	O
there	O
was	O
considerable	O
clinical	O
and	O
methodological	O
variation	O
between	O
studies	O
and	O
heterogeneity	O
in	O
their	O
results	O
.	O

To	O
provide	O
an	O
overview	O
,	O
we	O
first	O
reported	O
the	O
range	O
of	O
results	O
for	O
all	O
studies	O
and	O
then	O
the	O
range	O
and	O
median	O
results	O
with	O
inter	O
-	O
quartile	O
ranges	O
(	O
IQR	O
)	O
of	O
studies	O
according	O
to	O
analytical	O
strategy	O
(	O
mean	O
change	O
or	O
threshold	O
approach	O
).	O

To	O
facilitate	O
exploration	O
of	O
reasons	O
for	O
heterogeneity	O
,	O
we	O
then	O
pooled	O
results	O
of	O
studies	O
using	O
mean	O
change	O
approach	O
with	O
inverse	O
-	O
variance	O
meta	O
-	O
analysis	O
using	O
random	O
effects	O
models	O
.	O

We	O
studied	O
the	O
association	O
with	O
baseline	O
pain	O
scores	O
in	O
three	O
different	O
analyses	O
.	O

First	O
,	O
we	O
explored	O
the	O
impact	O
of	O
the	O
average	O
population	O
baseline	O
pain	O
in	O
a	O
mixed	O
-	O
effects	O
meta	O
-	O
regression	O
(	O
acknowledging	O
the	O
limitations	O
of	O
aggregated	O
data	O
-	O
level	O
analysis	O
[	O
24	O
]).	O

Second	O
,	O
we	O
pooled	O
individual	O
patient	O
data	O
to	O
estimate	O
the	O
MCID	O
(	O
absolute	O
and	O
relative	O
changes	O
)	O
using	O
a	O
two	O
-	O
stage	O
individual	O
participant	O
data	O
meta	O
-	O
analysis	O
.	O

In	O
these	O
models	O
,	O
MCIDs	O
were	O
first	O
estimated	O
in	O
each	O
individual	O
study	O
using	O
a	O
mixed	O
model	O
based	O
on	O
all	O
repeated	O
measurements	O
and	O
participant	O
specific	O
random	O
effects	O
to	O
capture	O
the	O
serial	O
correlation	O
within	O
each	O
participant	O
.	O

Results	O
were	O
then	O
pooled	O
using	O
random	O
-	O
effects	O
inverse	O
-	O
variance	O
meta	O
-	O
analysis	O
.	O

Third	O
,	O
we	O
used	O
the	O
same	O
model	O
to	O
derive	O
outcomes	O
measured	O
at	O
different	O
time	O
points	O
in	O
studies	O
with	O
multiple	O
measurements	O
per	O
patients	O
(	O
i	O
.	O
e	O
.	O
the	O
use	O
of	O
a	O
‘	O
moving	O
baseline	O
’).	O

We	O
furthermore	O
used	O
subgroup	O
analyses	O
to	O
explore	O
whether	O
between	O
-	O
study	O
variation	O
was	O
explained	O
by	O
differences	O
in	O
other	O
clinical	O
and	O
methodological	O
factors	O
including	O
clinical	O
condition	O
,	O
type	O
of	O
pain	O
scale	O
(	O
VAS	O
vs	O
.	O
NRS	O
),	O
directionality	O
of	O
global	O
transition	O
scale	O
(	O
one	O
-	O
sided	O
vs	O
.	O
two	O
-	O
sided	O
scale	O
),	O
definition	O
of	O
minimum	O
clinically	O
important	O
change	O
(	O
one	O
category	O
vs	O
.	O
several	O
categories	O
improvement	O
vs	O
.	O
distinction	O
between	O
meaningful	O
and	O
non	O
-	O
meaningful	O
change	O
),	O
number	O
of	O
pain	O
assessments	O
per	O
patients	O
(	O
single	O
vs	O
.	O
multiple	O
assessments	O
adjusted	O
for	O
correlation	O
vs	O
.	O
multiple	O
unadjusted	O
assessments	O
),	O
risk	O
of	O
attrition	O
bias	O
(	O
low	O
vs	O
.	O
high	O
or	O
unclear	O
)	O
and	O
risk	O
of	O
non	O
-	O
representative	O
sample	O
(	O
low	O
vs	O
.	O
high	O
or	O
unclear	O
).	O

Finally	O
,	O
we	O
used	O
the	O
same	O
analysis	O
strategy	O
for	O
the	O
substantial	O
clinically	O
important	O
difference	O
for	O
pain	O
relief	O
(	O
absolute	O
and	O
relative	O
change	O
)	O
and	O
the	O
minimum	O
and	O
substantial	O
clinically	O
important	O
differences	O
for	O
worsening	O
of	O
pain	O
(	O
absolute	O
and	O
relative	O
change	O
).	O

All	O
data	O
analyses	O
were	O
done	O
using	O
Stata	O
/	O
IC	O
version	O
13	O
.	O

Results	O

Study	O
selection	O

We	O
screened	O
1553	O
database	O
records	O
and	O
read	O
273	O
full	O
-	O
text	O
publications	O
(	O
Fig	O
.	O
1	O
).	O

We	O
excluded	O
237	O
publications	O
,	O
mostly	O
because	O
they	O
included	O
patients	O
with	O
chronic	O
pain	O
(	O
n	O
=	O
63	O
)	O
or	O
multi	O
-	O
dimensional	O
pain	O
scales	O
(	O
n	O
=	O
53	O
).	O

Thus	O
,	O
we	O
included	O
36	O
publications	O
[	O
21	O
,	O
25	O
–	O
59	O
]	O
reporting	O
37	O
studies	O
(	O
8479	O
patients	O
).	O
Fig	O
.	O
1Flow	O
chart	O
of	O
study	O
identification	O
.	O

MCID	O
=	O
Minimal	O
Clinically	O
Important	O
Difference	O
,	O
aAdditional	O
records	O
identified	O
through	O
“	O
related	O
papers	O
”	O
function	O
in	O
databases	O
and	O
reference	O
lists	O
of	O
screened	O
papers	O
,	O
bTwo	O
records	O
include	O
both	O
acute	O
and	O
chronic	O
pain	O
studies	O
,	O
cIncludes	O
studies	O
in	O
which	O
MCID	O
was	O
not	O
based	O
on	O
subjective	O
patient	O
-	O
reported	O
assessment	O
of	O
pain	O
relief	O

Characteristics	O
of	O
included	O
studies	O

The	O
majority	O
of	O
studies	O
were	O
based	O
in	O
emergency	O
departments	O
and	O
included	O
a	O
mix	O
of	O
patients	O
with	O
acute	O
pain	O
of	O
both	O
traumatic	O
and	O
non	O
-	O
traumatic	O
origin	O
(	O
10	O
studies	O
)	O
or	O
unspecified	O
pain	O
(	O
7	O
studies	O
).	O

Additional	O
studies	O
included	O
patients	O
with	O
post	O
-	O
operative	O
pain	O
,	O
cancer	B-DS
-	O
related	O
pain	O
,	O
sickle	B-DS
cell	I-DS
crisis	I-DS
,	O
rheumatic	O
pain	O
,	O
abdominal	O
pain	O
,	O
low	O
back	O
pain	O
,	O
or	O
headache	O
(	O
Tables	O
1	O
and	O
2	O
).	O

All	O
studies	O
were	O
published	O
in	O
English	O
.	O
Table	O
1Studies	O
determining	O
minimal	O
clinically	O
important	O
difference	O
as	O
a	O
mean	O
changea	O
(	O
35	O
studies	O
,	O
7894	O
patients	O
)	O
StudynPatient	O
characteristicsMethodological	O
characteristicsMCIDClinical	O
conditionAge	O
,	O
years	O
(	O
range	O
)	O
b	O
Male	O
sex	O
,	O
%	O
Baseline	O
pain	O
,	O
mmPain	O
scaleTransition	O
scale	O
(	O
directionality	O
,	O
categories	O
)	O
Follow	O
-	O
up	O
(	O
Analysis	O
adjusted	O
)	O
c	O
Category	O
defining	O
MCIDAbsoluted	O
mm	O
(	O
95	O
%	O
CI	O
)	O
Relativee	O
%	O
(	O
95	O
%	O
CI	O
)	O
Aicher	O
[	O
25	O
]	O
1743Headache38h	O
(	O
16	O
–	O
72	O
)	O
2464VAS1	O
-	O
sided	O
,	O
4	O
catSingleLess	O
good	O
efficacy27	O
(	O
25	O
–	O
29	O
)	O
NRBailey	O
[	O
26	O
]	O
202Mixedg	O
12	O
(	O
8	O
–	O
17	O
)	O
57NRNRS2	O
-	O
sided	O
,	O
5	O
catSingleA	O
little	O
better10	O
(	O
0	O
–	O
20	O
)	O
h	O
NRBarton	O
2002	O
(	O
reported	O
in	O
Jensen	O
2002	O
[	O
43	O
])	O
125Post	O
-	O
operation	O
pain	O
(	O
laparotomy	O
)	O
410NRVAS1	O
-	O
sided	O
,	O
5	O
catMultiple	O
(	O
unclear	O
)	O
A	O
little	O
relief9	O
(	O
7	O
–	O
12	O
)	O
13	O
(	O
8	O
–	O
17	O
)	O
Bernstein	O
[	O
27	O
]	O
135Unspecified42	O
(	O
21	O
–	O
65	O
)	O
45100h	O
NRS1	O
-	O
sided	O
,	O
5	O
catSingleA	O
little	O
relief21	O
(	O
18	O
–	O
24	O
)	O
NRBijur	O
[	O
28	O
]	O
f	O
108Unspecified44	O
(	O
21	O
–	O
85	O
)	O
4073VAS	O
+	O
NRS2	O
-	O
sided	O
,	O
5	O
catMultiple	O
(	O
no	O
)	O
A	O
little	O
less	O
pain16	O
(	O
11	O
–	O
21	O
)	O
22	O
(	O
15	O
–	O
28	O
)	O
Bijur	O
[	O
29	O
]	O
f	O
195Unspecified742774NRS2	O
-	O
sided	O
,	O
5	O
catMultiple	O
(	O
yes	O
)	O
A	O
little	O
less	O
pain15	O
(	O
14	O
–	O
17	O
)	O
24	O
(	O
21	O
–	O
27	O
)	O
Bijur	O
[	O
30	O
]	O
f	O
214Unspecified743486NRS2	O
-	O
sided	O
,	O
5	O
catMultiple	O
(	O
yes	O
)	O
A	O
little	O
less	O
pain14	O
(	O
12	O
–	O
15	O
)	O
22	O
(	O
19	O
–	O
25	O
)	O
Bird	O
[	O
31	O
]	O
77Isolated	O
extremity	O
trauma386252VAS2	O
-	O
sided	O
,	O
5	O
catMultiple	O
(	O
no	O
)	O
A	O
little	O
less	O
pain20	O
(	O
15	O
–	O
25	O
)	O
NRBulloch	O
[	O
32	O
]	O
121Mixedg	O
(	O
65	O
%	O
traumatic	O
,	O
35	O
%	O
non	O
-	O
traumatic	O
)	O
10	O
(	O
5	O
–	O
16	O
)	O
5660h	O
VAS2	O
-	O
sided	O
,	O
5	O
catMultiple	O
(	O
no	O
)	O
A	O
little	O
less	O
pain17	O
(	O
11	O
–	O
23	O
)	O
NRCepeda	O
[	O
33	O
]	O
700Post	O
-	O
operation	O
pain	O
(	O
mixed	O
)	O
41	O
(	O
16	O
–	O
88	O
)	O
3879NRS1	O
-	O
sided	O
,	O
5	O
catMultiple	O
(	O
yes	O
)	O
Minimal	O
improvement17	O
(	O
10	O
–	O
20	O
)	O
h	O
20	O
(	O
13	O
–	O
30	O
)	O
h	O
Chow	O
[	O
34	O
]	O
105Pain	O
flare	O
after	O
radiotherapy70h	O
5650NRS2	O
-	O
sided	O
,	O
3	O
catMultiple	O
(	O
no	O
)	O
Better23	O
(	O
20	O
–	O
26	O
)	O
NRDegerli	O
[	O
35	O
]	O
306Thoraco	O
-	O
abdominal	O
pain	O
(	O
non	O
-	O
traumatic	O
)	O
42	O
(	O
17	O
–	O
83	O
)	O
4067VAS2	O
-	O
sided	O
,	O
5	O
catMultiple	O
(	O
no	O
)	O
A	O
little	O
less	O
pain25	O
(	O
23	O
–	O
26	O
)	O
NRFarrar	O
[	O
36	O
]	O
134Cancer	B-DS
-	O
related	O
breakthrough	O
pain55	O
(	O
21	O
–	O
87	O
)	O
53NRNRS1	O
-	O
sided	O
,	O
5	O
catMultiple	O
(	O
yes	O
)	O
Slight	O
relief13	O
–	O
19j	O
16	O
–	O
34j	O
Fosnocht	O
[	O
37	O
]	O
1490Mixedg	O
36	O
(	O
18	O
–	O
89	O
)	O
4763VAS2	O
-	O
sided	O
,	O
5	O
catMultiple	O
(	O
no	O
)	O
A	O
little	O
less	O
pain21	O
(	O
19	O
–	O
23	O
)	O
NRGallagher	O
[	O
38	O
]	O
f	O
96Mixedg	O
37	O
(	O
19	O
–	O
71	O
)	O
4564VAS2	O
-	O
sided	O
,	O
5	O
catMultiple	O
(	O
yes	O
)	O
A	O
little	O
less	O
pain15	O
(	O
11	O
–	O
18	O
)	O
17	O
(	O
6	O
–	O
29	O
)	O
Gallagher	O
[	O
39	O
]	O
f	O
101Abdominal	O
pain40	O
(	O
15	O
–	O
88	O
)	O
3965VAS2	O
-	O
sided	O
,	O
5	O
catMultiple	O
(	O
yes	O
)	O
A	O
little	O
less	O
pain18	O
(	O
14	O
–	O
21	O
)	O
23	O
(	O
12	O
–	O
33	O
)	O
Grilo	O
[	O
40	O
]	O
50Rheumatic	O
conditions49	O
(	O
16	O
–	O
85	O
)	O
4478VAS1	O
-	O
sided	O
,	O
5	O
catSingleModerate	O
relief40i	O
NRGrotle	O
[	O
41	O
]	O
54Acute	O
low	O
back	O
pain382739VAS	O
+	O
NRS2	O
-	O
sided	O
,	O
6	O
catSingleSlightly	O
improved34	O
(	O
20	O
–	O
48	O
)	O
Holdgate	O
[	O
42	O
]	O
f	O
79Unspecified53	O
(	O
21	O
–	O
93	O
)	O
NR54VAS	O
+	O
NRS2	O
-	O
sided	O
,	O
5	O
catMultiple	O
(	O
yes	O
)	O
A	O
bit	O
better16	O
(	O
12	O
–	O
20	O
)	O
34	O
(	O
27	O
–	O
41	O
)	O
Kelly	O
[	O
44	O
]	O
Kelly	O
[	O
45	O
,	O
46	O
]	O
156Mixedg	O
(	O
43	O
%	O
traumatic	O
,	O
57	O
%	O
non	O
-	O
traumatic	O
)	O
44	O
(	O
16	O
–	O
97	O
)	O
5651VAS2	O
-	O
sided	O
,	O
5	O
catMultiple	O
(	O
unclear	O
)	O
A	O
little	O
better8	O
(	O
4	O
–	O
12	O
)	O
NRKendrick	O
2005	O
[	O
47	O
]	O
356Mixedg	O
(	O
35	O
%	O
traumatic	O
,	O
65	O
%	O
non	O
-	O
traumatic	O
)	O
41h	O
4266NRS2	O
-	O
sided	O
,	O
5	O
catMultiple	O
(	O
no	O
)	O
A	O
little	O
less	O
pain15	O
(	O
13	O
–	O
16	O
)	O
NRLopez	O
[	O
21	O
]	O
74Sickle	O
cell	O
crisisNRNR79VAS2	O
-	O
sided	O
,	O
5	O
catMultiple	O
(	O
no	O
)	O
A	O
little	O
better14	O
(	O
11	O
–	O
16	O
)	O
h	O
,	O
k	O
NRMark	O
[	O
48	O
]	O
186Unspecified49	O
(	O
15	O
–	O
87	O
)	O
3865VAS2	O
-	O
sided	O
,	O
5	O
catSingleA	O
little	O
better17	O
(	O
14	O
–	O
20	O
)	O
k	O
NRMartin	O
[	O
49	O
]	O
95Third	O
molar	O
extraction304033VAS2	O
-	O
sided	O
,	O
7	O
catSingleMuch	O
improved	O
or	O
best	O
ever23i	O
72i	O
Martin	O
[	O
49	O
]	O
63Third	O
molar	O
extraction254035DoDoDoDo25i	O
69i	O
Martin	O
[	O
49	O
]	O
62Third	O
molar	O
extraction275030DoDoDoDo29i	O
85i	O
McConahay	O
[	O
50	O
]	O
126Mixedg	O
(	O
48	O
%	O
traumatic	O
,	O
52	O
%	O
non	O
-	O
traumatic	O
)	O
9	O
(	O
5	O
–	O
12	O
)	O
5683VAS2	O
-	O
sided	O
,	O
5	O
catSingleA	O
little	O
less	O
pain24	O
(	O
17	O
–	O
31	O
)	O
NRMohan	O
[	O
51	O
]	O
f	O
125Unspecified35h	O
4446VAS	O
+	O
NRS2	O
-	O
sided	O
,	O
5	O
catMultiple	O
(	O
yes	O
)	O
A	O
bit	O
better13	O
(	O
9	O
–	O
17	O
)	O
18	O
(	O
1	O
–	O
35	O
)	O
Myrvik	O
[	O
52	O
]	O
28Sickle	O
cell	O
crisis15	O
(	O
8	O
–	O
18	O
)	O
5075h	O
VAS	O
+	O
NRS2	O
-	O
sided	O
,	O
5	O
catMultiple	O
(	O
unclear	O
)	O
A	O
little	O
better10	O
(	O
4	O
–	O
15	O
)	O
NRPowell	O
[	O
53	O
]	O
73Mixed	O
(	O
63	O
%	O
traumatic	O
,	O
37	O
%	O
non	O
-	O
traumatic	O
)	O
12	O
(	O
8	O
–	O
15	O
)	O
NR60VAS2	O
-	O
sided	O
,	O
5	O
catMultiple	O
(	O
yes	O
)	O
A	O
bit	O
better11i	O
NRRasmussen	O
2002	O
(	O
reported	O
in	O
Jensen	O
2002	O
[	O
43	O
])	O
123Post	O
-	O
operation	O
pain	O
(	O
knee	O
surgery	O
)	O
6534NRVAS1	O
-	O
sided	O
,	O
5	O
catMultiple	O
(	O
unclear	O
)	O
A	O
little	O
relief13	O
(	O
10	O
–	O
17	O
)	O
18	O
(	O
14	O
–	O
22	O
)	O
Sloman	O
[	O
54	O
]	O
150Post	O
-	O
operation	O
pain	O
(	O
mixed	O
)	O
47	O
(	O
14	O
–	O
89	O
)	O
5367NRS1	O
-	O
sided	O
,	O
5	O
catSingleMinimal	O
relief18i	O
36	O
(	O
21	O
–	O
51	O
)	O
Stahmer	O
[	O
55	O
]	O
81Mixedg	O
(	O
31	O
%	O
traumatic	O
,	O
69	O
%	O
non	O
-	O
traumatic	O
)	O
38	O
(	O
16	O
–	O
87	O
)	O
4468NRS1	O
-	O
sided	O
,	O
5	O
catSingleSome	O
relief	O
or	O
partial	O
reliefNR30	O
(	O
18	O
–	O
42	O
)	O
Todd	O
[	O
56	O
]	O
48Trauma35h	O
(	O
17	O
–	O
76	O
)	O
6956VAS2	O
-	O
sided	O
,	O
5	O
catMultiple	O
(	O
no	O
)	O
A	O
little	O
less	O
pain16	O
(	O
10	O
–	O
22	O
)	O
NRVoepel	O
-	O
Lewis	O
[	O
59	O
]	O
113Post	O
-	O
operation	O
pain	O
(	O
e	O
.	O
g	O
.	O
spinal	O
fusion	O
,	O
splenectomy	O
)	O
13	O
(	O
7	O
–	O
16	O
)	O
43NRNRS2	O
-	O
sided	O
,	O
5	O
catMultiple	O
(	O
yes	O
)	O
A	O
little	O
better10	O
(	O
5	O
–	O
15	O
)	O
NR	O
aMean	O
change	O
in	O
pain	O
score	O
among	O
patients	O
with	O
minimum	O
improvement	O
of	O
pain	O
bMean	O
(	O
range	O
)	O
if	O
not	O
otherwise	O
indicated	O
,	O
cEstimate	O
based	O
on	O
single	O
or	O
multiple	O
follow	O
-	O
up	O
measurements	O
(	O
were	O
standard	O
errors	O
adjusted	O
for	O
dependency	O
between	O
multiple	O
measurements	O
?)	O
dAbsolute	O
=	O
mm	O
reduction	O
on	O
a	O
100	O
mm	O
scale	O
eRelative	O
=	O
%	O
reduction	O
from	O
baseline	O
fIndividual	O
patient	O
data	O
provided	O
by	O
authors	O
gMixed	O
patient	O
population	O
recruited	O
at	O
Hospital	O
Emergency	O
Department	O
hData	O
is	O
median	O
(	O
inter	O
-	O
quartile	O
range	O
)	O
i95	O
%	O
CI	O
unavailable	O
jEstimates	O
for	O
subgroups	O
with	O
different	O
baseline	O
pain	O
kPatients	O
with	O
minimal	O
improvement	O
and	O
worsening	O
of	O
pain	O
were	O
combined	O
MCID	O
minimum	O
clinically	O
important	O
difference	O
,	O
VAS	O
visual	O
analogue	O
scale	O
,	O
NRS	O
numeric	O
rating	O
scale	O
,	O
CI	O
confidence	O
interval	O
,	O
NR	O
not	O
reported	O
Table	O
2Studies	O
determining	O
minimal	O
clinically	O
important	O
difference	O
as	O
a	O
threshold	O
valuea	O
(	O
7	O
studies	O
,	O
2602	O
patients	O
)	O
StudynPatient	O
characteristicsMethodological	O
characteristicsMCIDClinical	O
conditionAge	O
,	O
yearsb	O
Male	O
sex	O
,	O
%	O
Baseline	O
pain	O
,	O
mmPain	O
scaleTransition	O
scale	O
(	O
directionality	O
,	O
categories	O
)	O
Anchor	O
questionCategories	O
defining	O
respondersAbsolute	O
,	O
mm	O
(	O
sensitivity	O
,	O
specificity	O
)	O
Relative	O
,	O
%	O
(	O
sensitivity	O
,	O
specificity	O
)	O
Aicher	O
[	O
25	O
]	O
1743Headache38b	O
(	O
16	O
–	O
72	O
)	O
2464VAS1	O
-	O
sided	O
,	O
4	O
cat	O
(	O
0	O
to	O
+	O
4	O
points	O
")"""	O
How	O
do	O
you	O
assess	O
the	O
efficacy	O
of	O
your	O
tablets	O
"?"""	O
Good	O
(+	O
3	O
)	O
or	O
very	O
good	O
(+	O
4	O
)	O
35	O
(	O
76	O
%,	O
76	O
%)	O
NRGrotle	O
[	O
41	O
]	O
54Acute	O
low	O
back	O
pain382739VAS	O
+	O
NRS2	O
-	O
sided	O
,	O
6	O
cat	O
(–	O
1	O
to	O
+	O
4	O
points	O
")"""	O
To	O
which	O
extent	O
has	O
your	O
back	O
problem	O
changed	O
"?"""	O
Slightly	O
improved	O
(+	O
1	O
),	O
much	O
better	O
(+	O
2	O
),	O
very	O
much	O
better	O
(+	O
3	O
),	O
or	O
completely	O
gone	O
(+	O
4	O
)	O
10	O
(	O
87	O
%,	O
81	O
%)	O
NRMartin	O
[	O
49	O
]	O
63Post	O
-	O
operation	O
pain	O
(	O
third	O
molar	O
extraction	O
)	O
304033VAS2	O
-	O
sided	O
,	O
7	O
cat	O
(–	O
3	O
to	O
+	O
3	O
points	O
)	O
Assessment	O
of	O
recovery	O
following	O
treatmentMuch	O
improved	O
(+	O
2	O
)	O
or	O
best	O
ever	O
(+	O
3	O
)	O
10	O
(	O
70	O
%,	O
82	O
%)	O
50	O
(	O
82	O
%,	O
82	O
%)	O
Martin	O
[	O
49	O
]	O
62Post	O
-	O
operation	O
pain	O
(	O
third	O
molar	O
extraction	O
)	O
254035DoDoDoDo10	O
(	O
71	O
%,	O
71	O
%)	O
50	O
(	O
83	O
%,	O
86	O
%)	O
Martin	O
[	O
49	O
]	O
95Post	O
-	O
operation	O
pain	O
(	O
third	O
molar	O
extraction	O
)	O
275030DoDoDoDo10	O
(	O
87	O
%,	O
69	O
%)	O
50	O
(	O
97	O
%,	O
82	O
%)	O
Tsze	O
[	O
57	O
]	O
314Mixedd	O
1050NRVAS2	O
-	O
sided	O
,	O
5	O
cat	O
(–	O
2	O
to	O
+	O
2	O
points	O
)	O
Assessment	O
of	O
change	O
in	O
pain	O
following	O
treatmentA	O
little	O
better	O
(+	O
1	O
)	O
10	O
(	O
76	O
%,	O
74	O
%)	O
15	O
(	O
78	O
%,	O
79	O
%)	O
Tubach	O
[	O
58	O
]	O
271Rotator	B-DS
cuff	I-DS
syndrome483868NRS2	I-DS
-	O
sided	O
,	O
15	O
cat	O
(–	O
7	O
to	O
+	O
7	O
points	O
)	O
Assessment	O
of	O
response	O
to	O
treatmentA	O
good	O
deal	O
better	O
(+	O
5	O
)	O
or	O
a	O
great	O
deal	O
better	O
(+	O
6	O
)	O
34	O
–	O
63c	O
(	O
75	O
%,	O
NR	O
)	O
NR	O
MCID	O
minimum	O
clinically	O
important	O
difference	O
(	O
mm	O
change	O
on	O
a	O
100	O
mm	O
scale	O
),	O
VAS	O
visual	O
analogue	O
scale	O
,	O
NRS	O
numeric	O
rating	O
scale	O
,	O
NR	O
not	O
reported	O
aThreshold	O
in	O
pain	O
reduction	O
associated	O
with	O
the	O
best	O
accuracy	O
(	O
sensitivity	O
and	O
specificity	O
)	O
for	O
identifying	O
improved	O
patients	O
bData	O
is	O
median	O
(	O
range	O
)	O
cEstimates	O
for	O
subgroups	O
with	O
different	O
baseline	O
pain	O
cMixed	O
patient	O
population	O
recruited	O
at	O
Hospital	O
Emergency	O
Department	O

Twenty	O
studies	O
assessed	O
pain	O
using	O
a	O
100	O
mm	O
VAS	O
(	O
or	O
the	O
similar	O
Color	O
Analog	O
Scale	O
),	O
and	O
12	O
studies	O
used	O
an	O
11	O
-	O
point	O
NRS	O
(	O
0	O
–	O
10	O
),	O
while	O
five	O
studies	O
used	O
both	O
scales	O
.	O

In	O
32	O
studies	O
,	O
patients	O
compared	O
their	O
current	O
pain	O
intensity	O
with	O
pain	O
at	O
their	O
previous	O
assessment	O
,	O
while	O
they	O
were	O
asked	O
to	O
assess	O
the	O
effect	O
of	O
their	O
treatment	O
in	O
five	O
studies	O
[	O
25	O
,	O
49	O
,	O
58	O
].	O

Transition	O
scales	O
were	O
either	O
two	O
-	O
sided	O
(	O
29	O
studies	O
)	O
with	O
3	O
–	O
15	O
response	O
categories	O
for	O
both	O
improvement	O
and	O
deterioration	O
,	O
or	O
one	O
-	O
sided	O
(	O
8	O
studies	O
)	O
with	O
five	O
response	O
categories	O
addressing	O
only	O
improvement	O
.	O

For	O
studies	O
using	O
the	O
mean	O
change	O
approach	O
,	O
the	O
majority	O
defined	O
the	O
minimum	O
clinically	O
important	O
improvement	O
as	O
a	O
one	O
-	O
category	O
improvement	O
on	O
the	O
transition	O
scale	O
(	O
31	O
studies	O
).	O

The	O
response	O
categories	O
were	O
similar	O
with	O
wordings	O
such	O
as	O
‘	O
a	O
little	O
less	O
pain	O
’,	O
‘	O
a	O
bit	O
better	O
’,	O
‘	O
slightly	O
improved	O
’,	O
or	O
‘	O
slight	O
relief	O
’.	O

In	O
four	O
studies	O
,	O
the	O
MCID	O
was	O
defined	O
as	O
the	O
mean	O
change	O
in	O
pain	O
score	O
among	O
patients	O
with	O
a	O
one	O
-	O
or	O
two	O
-	O
category	O
improvement	O
,	O
thereby	O
combing	O
patients	O
answering	O
‘	O
some	O
relief	O
’	O
and	O
‘	O
partial	O
relief	O
’	O
[	O
55	O
],	O
or	O
‘	O
much	O
improved	O
’	O
and	O
‘	O
best	O
ever	O
’	O
[	O
49	O
–	O
51	O
].	O

Finally	O
,	O
two	O
studies	O
differentiated	O
between	O
non	O
-	O
important	O
and	O
important	O
change	O
,	O
using	O
the	O
categories	O
‘	O
inadequate	O
relief	O
’	O
and	O
‘	O
moderate	O
relief	O
’	O
in	O
one	O
study	O
[	O
40	O
],	O
and	O
‘	O
poor	O
’	O
and	O
‘	O
less	O
good	O
’	O
efficiency	O
of	O
treatment	O
in	O
another	O
[	O
25	O
]	O
(	O
Table	O
1	O
).	O

Studies	O
using	O
the	O
threshold	O
approach	O
had	O
large	O
variation	O
in	O
transition	O
scales	O
and	O
definitions	O
of	O
responders	O
versus	O
non	O
-	O
responders	O
;	O
patients	O
were	O
regarded	O
as	O
importantly	O
improved	O
if	O
they	O
indicated	O
a	O
one	O
-	O
category	O
relief	O
in	O
two	O
studies	O
[	O
41	O
,	O
57	O
],	O
while	O
they	O
needed	O
a	O
five	O
-	O
category	O
improvement	O
in	O
another	O
[	O
58	O
]	O
(	O
Table	O
2	O
).	O

Pain	O
intensity	O
was	O
assessed	O
at	O
baseline	O
and	O
a	O
single	O
follow	O
-	O
up	O
measurement	O
in	O
14	O
studies	O
,	O
while	O
it	O
was	O
assessed	O
at	O
multiple	O
(	O
from	O
2	O
to	O
16	O
)	O
follow	O
-	O
ups	O
with	O
intervals	O
between	O
10	O
and	O
45	O
minutes	O
in	O
23	O
studies	O
.	O

The	O
latter	O
group	O
then	O
derived	O
their	O
outcome	O
as	O
the	O
summarised	O
mean	O
difference	O
in	O
pain	O
score	O
from	O
the	O
patients	O
’	O
previous	O
pain	O
assessment	O
when	O
they	O
reported	O
minimum	O
relief	O
(	O
i	O
.	O
e	O
.	O
a	O
series	O
of	O
‘	O
moving	O
baselines	O
’).	O

In	O
eight	O
of	O
these	O
studies	O
,	O
the	O
P	O
values	O
of	O
analyses	O
were	O
adjusted	O
for	O
correlation	O
between	O
estimates	O
,	O
for	O
example	O
,	O
with	O
Generalised	O
Estimation	O
Equation	O
,	O
while	O
the	O
remaining	O
studies	O
either	O
made	O
no	O
adjustment	O
or	O
did	O
not	O
report	O
this	O
.	O

Access	O
to	O
individual	O
patient	O
data	O
increased	O
the	O
number	O
of	O
studies	O
with	O
adjusted	O
estimates	O
to	O
11	O
.	O

In	O
10	O
studies	O
,	O
the	O
MCID	O
was	O
defined	O
as	O
a	O
numeric	O
change	O
for	O
all	O
patients	O
with	O
minimum	O
change	O
,	O
regardless	O
of	O
whether	O
pain	O
had	O
improved	O
or	O
worsened	O
.	O

After	O
contacting	O
authors	O
,	O
separate	O
estimates	O
for	O
pain	O
relief	O
were	O
available	O
from	O
eight	O
of	O
these	O
.	O

MCID	O
regardless	O
of	O
analytical	O
approach	O

Standardised	O
to	O
a	O
100	O
-	O
mm	O
scale	O
,	O
the	O
absolute	O
MCID	O
in	O
30	O
studies	O
ranged	O
from	O
8	O
to	O
40	O
mm	O
,	O
and	O
the	O
relative	O
difference	O
in	O
15	O
studies	O
ranged	O
from	O
13	O
%	O
to	O
85	O
%.	O

MCIDs	O
in	O
studies	O
using	O
the	O
mean	O
change	O
approach	O

The	O
determination	O
of	O
the	O
MCID	O
was	O
based	O
on	O
a	O
mean	O
change	O
approach	O
in	O
35	O
studies	O
,	O
of	O
which	O
30	O
(	O
6598	O
patients	O
)	O
were	O
included	O
in	O
our	O
analyses	O
and	O
five	O
were	O
disregarded	O
(	O
see	O
below	O
).	O

Twenty	O
-	O
nine	O
studies	O
(	O
6517	O
patients	O
)	O
reported	O
absolute	O
values	O
ranging	O
from	O
8	O
to	O
40	O
mm	O
,	O
with	O
a	O
median	O
of	O
17	O
mm	O
(	O
IQR	O
14	O
–	O
23	O
mm	O
)	O
(	O
Fig	O
.	O
2a	O
).	O

Only	O
nine	O
of	O
the	O
30	O
studies	O
reported	O
relative	O
MCIDs	O
,	O
but	O
access	O
to	O
individual	O
patient	O
data	O
made	O
relative	O
values	O
available	O
from	O
14	O
studies	O
(	O
1617	O
patients	O
)	O
ranging	O
from	O
13	O
%	O
to	O
85	O
%,	O
with	O
a	O
median	O
of	O
23	O
%	O
(	O
IQR	O
18	O
–	O
36	O
%)	O
(	O
Fig	O
.	O
2b	O
).	O
Fig	O
.	O
2	O
a	O
Range	O
of	O
absolute	O
minimal	O
clinically	O
important	O
differences	O
in	O
acute	O
pain	O
assessed	O
by	O
the	O
mean	O
change	O
approach	O
*	O
(	O
29	O
studies	O
,	O
6517	O
patients	O
).	O
*	O
MCID	O
assessed	O
as	O
the	O
mean	O
change	O
in	O
pain	O
score	O
among	O
patients	O
with	O
minimal	O
improvement	O
of	O
pain	O
,	O
MCID	O
=	O
Minimal	O
Clinically	O
Important	O
Difference	O
(	O
mm	O
reduction	O
on	O
a	O
100	O
mm	O
scale	O
),	O
Studies	O
where	O
standard	O
error	O
(	O
or	O
data	O
for	O
obtaining	O
this	O
)	O
was	O
unavailable	O
are	O
presented	O
as	O
point	O
estimates	O
without	O
95	O
%	O
CI	O
(	O
NA	O
=	O
not	O
applicable	O
).	O
b	O
Range	O
of	O
relative	O
minimal	O
clinically	O
important	O
differences	O
in	O
acute	O
pain	O
assessed	O
by	O
the	O
mean	O
change	O
approach	O
*	O
(	O
14	O
studies	O
,	O
1617	O
patients	O
).	O
*	O
MCID	O
assessed	O
as	O
the	O
mean	O
change	O
in	O
pain	O
score	O
among	O
patients	O
with	O
minimal	O
improvement	O
of	O
pain	O
,	O
MCID	O
=	O
Minimal	O
Clinically	O
Important	O
Difference	O
(%	O
reduction	O
from	O
baseline	O
),	O
Studies	O
where	O
standard	O
error	O
(	O
or	O
data	O
for	O
obtaining	O
this	O
)	O
was	O
unavailable	O
are	O
presented	O
as	O
point	O
estimates	O
without	O
95	O
%	O
CI	O
(	O
NA	O
=	O
not	O
applicable	O
)	O

For	O
data	O
syntheses	O
,	O
we	O
did	O
not	O
include	O
results	O
from	O
five	O
of	O
the	O
35	O
studies	O
(	O
1567	O
patients	O
)	O
as	O
they	O
did	O
not	O
differentiate	O
between	O
pain	O
relief	O
and	O
pain	O
worsening	O
[	O
21	O
,	O
48	O
],	O
because	O
median	O
(	O
and	O
not	O
mean	O
)	O
differences	O
in	O
pain	O
were	O
reported	O
[	O
26	O
,	O
33	O
],	O
or	O
because	O
outcomes	O
were	O
reported	O
for	O
subgroups	O
and	O
no	O
overall	O
estimate	O
could	O
be	O
derived	O
[	O
36	O
].	O

The	O
range	O
of	O
MCID	O
in	O
these	O
studies	O
was	O
comparable	O
to	O
the	O
included	O
studies	O
:	O
10	O
–	O
19	O
mm	O
.	O

An	O
additional	O
six	O
studies	O
(	O
493	O
patients	O
)	O
were	O
not	O
included	O
in	O
meta	O
-	O
analysis	O
since	O
information	O
about	O
standard	O
error	O
of	O
estimates	O
was	O
unavailable	O
[	O
40	O
,	O
49	O
,	O
53	O
,	O
54	O
].	O

The	O
results	O
from	O
these	O
studies	O
ranged	O
from	O
11	O
to	O
40	O
mm	O
.	O

We	O
had	O
data	O
usable	O
for	O
meta	O
-	O
analyses	O
from	O
23	O
studies	O
(	O
6024	O
patients	O
)	O
reporting	O
absolute	O
values	O
and	O
11	O
studies	O
(	O
1397	O
patients	O
)	O
reporting	O
relative	O
values	O
.	O

Meta	O
-	O
analyses	O
of	O
both	O
the	O
absolute	O
and	O
relative	O
values	O
showed	O
considerable	O
heterogeneity	O
:	O
I2	O
=	O
93	O
%,	O
P	O
<	O
0	O
.	O
001	O
and	O
I2	O
=	O
75	O
%,	O
P	O
<	O
0	O
.	O
001	O
(	O
Table	O
3	O
).	O

We	O
present	O
the	O
meta	O
-	O
analyses	O
for	O
completeness	O
and	O
as	O
a	O
basis	O
for	O
exploring	O
reasons	O
for	O
the	O
heterogeneity	O
,	O
but	O
stress	O
that	O
medians	O
and	O
interquartile	O
ranges	O
are	O
more	O
appropriate	O
descriptors	O
of	O
the	O
results	O
.	O
Table	O
3Clinically	O
important	O
differences	O
in	O
acute	O
painAnalysis	O
of	O
mediansa	O
Analysis	O
of	O
pooled	O
averageClinically	O
important	O
differenceRangeNumber	O
of	O
studies	O
(	O
patientsb	O
)	O
MCID	O
median	O
(	O
IQR	O
)	O
Number	O
of	O
studies	O
(	O
patientsb	O
)	O
MCID	O
pooled	O
average	O
(	O
95	O
%	O
CI	O
),	O
I2	O
c	O
Minimum	O
clinically	O
important	O
difference	O
for	O
pain	O
relief	O
Absolute	O
change	O
,	O
mm	O
Mean	O
change	O
approach8	O
to	O
4029	O
(	O
6517	O
)	O
17	O
(	O
14	O
to	O
23	O
)	O
23	O
(	O
6024	O
)	O
17	O
(	O
15	O
to	O
19	O
),	O
93	O
%	O
Threshold	O
approach10	O
to	O
356	O
(	O
2331	O
)	O
10	O
(	O
10	O
to	O
10	O
)	O
NANA	O
Relative	O
change	O
,	O
%	O
Mean	O
change	O
approach13	O
to	O
8514	O
(	O
1617	O
)	O
23	O
(	O
18	O
to	O
36	O
)	O
11	O
(	O
1397	O
)	O
22	O
(	O
19	O
to	O
26	O
),	O
75	O
%	O
Threshold	O
approach15	O
to	O
504	O
(	O
534	O
)	O
50	O
(	O
33	O
to	O
50	O
)	O
NANASubstantial	O
clinically	O
important	O
difference	O
for	O
pain	O
relief	O
Absolute	O
change	O
,	O
mm	O
Mean	O
change	O
approach18	O
to	O
5423	O
(	O
6114	O
)	O
32	O
(	O
24	O
to	O
38	O
)	O
21	O
(	O
5891	O
)	O
32	O
(	O
27	O
to	O
38	O
),	O
97	O
%	O
Relative	O
change	O
,	O
%	O
Mean	O
change	O
approach36	O
to	O
7811	O
(	O
1397	O
)	O
57	O
(	O
45	O
to	O
65	O
)	O
11	O
(	O
1397	O
)	O
57	O
(	O
47	O
to	O
67	O
),	O
94	O
%	O
Minimum	O
clinically	O
important	O
difference	O
for	O
pain	O
worsening	O
Absolute	O
change	O
,	O
mm	O
Mean	O
change	O
approach	O
−	O
21	O
to	O
–	O
818	O
(	O
3822	O
)−	O
11	O
(–	O
13	O
to	O
–	O
10	O
)	O
16	O
(	O
3644	O
)−	O
12	O
(–	O
14	O
to	O
–	O
11	O
),	O
62	O
%	O
Relative	O
change	O
,	O
%	O
Mean	O
change	O
approach	O
−	O
89	O
to	O
–	O
177	O
(	O
918	O
)−	O
44	O
(–	O
90	O
to	O
–	O
16	O
)	O
7	O
(	O
918	O
)−	O
35	O
(–	O
47	O
to	O
–	O
23	O
),	O
67	O
%	O
Substantial	O
clinically	O
important	O
difference	O
for	O
pain	O
worsening	O
Absolute	O
change	O
,	O
mm	O
Mean	O
change	O
approach	O
−	O
66	O
to	O
016	O
(	O
3663	O
)−	O
21	O
(–	O
28	O
to	O
–	O
16	O
)	O
14	O
(	O
3464	O
)−	O
24	O
(–	O
29	O
to	O
–	O
18	O
),	O
71	O
%	O
Relative	O
change	O
,	O
%	O
Mean	O
change	O
approach	O
−	O
292	O
to	O
–	O
187	O
(	O
918	O
)−	O
83	O
(–	O
292	O
to	O
–	O
18	O
)	O
7	O
(	O
918	O
)−	O
34	O
(–	O
49	O
to	O
–	O
19	O
),	O
20	O
%	O
MCID	O
minimum	O
clinically	O
important	O
difference	O
(	O
mm	O
or	O
%	O
reduction	O
on	O
a	O
100	O
mm	O
scale	O
),	O
SCID	O
substantial	O
clinically	O
important	O
difference	O
(	O
mm	O
or	O
%	O
reduction	O
on	O
a	O
100	O
mm	O
scale	O
),	O
IQR	O
inter	O
-	O
quartile	O
range	O
,	O
NA	O
not	O
applicable	O
aThe	O
median	O
is	O
based	O
on	O
studies	O
included	O
in	O
the	O
pooled	O
average	O
as	O
well	O
as	O
studies	O
with	O
unavailable	O
standard	O
errors	O
bTotal	O
number	O
of	O
patients	O
in	O
the	O
included	O
studies	O
cI2	O
is	O
the	O
percentage	O
of	O
the	O
variability	O
in	O
results	O
that	O
is	O
due	O
to	O
heterogeneity	O
rather	O
than	O
sampling	O
error	O
(	O
chance	O
);	O
I2	O
of	O
0	O
%	O
to	O
40	O
%	O
might	O
not	O
be	O
important	O
,	O
30	O
%	O
to	O
60	O
%	O
may	O
represent	O
moderate	O
heterogeneity	O
,	O
50	O
%	O
to	O
90	O
%	O
may	O
represent	O
substantial	O
heterogeneity	O
,	O
and	O
75	O
%	O
to	O
100	O
%	O
represents	O
considerable	O
heterogeneity	O

MCID	O
in	O
studies	O
using	O
the	O
threshold	O
approach	O

Seven	O
of	O
the	O
37	O
included	O
studies	O
(	O
2602	O
patients	O
)	O
determined	O
clinically	O
important	O
differences	O
as	O
a	O
threshold	O
to	O
differentiate	O
between	O
patients	O
with	O
or	O
without	O
relevant	O
pain	O
relief	O
.	O

Absolute	O
thresholds	O
ranged	O
from	O
10	O
to	O
35	O
mm	O
in	O
six	O
studies	O
(	O
2331	O
patients	O
)	O
with	O
a	O
median	O
of	O
10	O
mm	O
,	O
and	O
the	O
relative	O
threshold	O
ranged	O
from	O
15	O
%	O
to	O
50	O
%	O
in	O
four	O
studies	O
(	O
534	O
patients	O
)	O
(	O
Table	O
3	O
).	O

In	O
one	O
additional	O
study	O
[	O
58	O
],	O
patients	O
were	O
defined	O
as	O
responders	O
if	O
they	O
indicated	O
at	O
least	O
a	O
five	O
-	O
category	O
improvement	O
.	O

The	O
corresponding	O
clinically	O
important	O
differences	O
were	O
thus	O
higher	O
(	O
34	O
to	O
63	O
mm	O
depending	O
on	O
baseline	O
pain	O
)	O
than	O
in	O
studies	O
where	O
patients	O
only	O
needed	O
a	O
one	O
-	O
[	O
41	O
,	O
57	O
],	O
two	O
-	O
[	O
49	O
],	O
or	O
three	O
-	O
category	O
improvement	O
[	O
25	O
],	O
respectively	O
,	O
to	O
be	O
defined	O
as	O
responders	O
(	O
Table	O
2	O
).	O

Impact	O
of	O
baseline	O
pain	O
scores	O
on	O
the	O
MCID	O

Eleven	O
studies	O
had	O
assessed	O
the	O
possible	O
influence	O
of	O
baseline	O
pain	O
on	O
minimum	O
clinically	O
improvement	O
(	O
Appendix	O
3	O
).	O

Of	O
nine	O
studies	O
assessing	O
absolute	O
change	O
,	O
seven	O
reported	O
an	O
association	O
[	O
31	O
,	O
33	O
,	O
36	O
,	O
43	O
,	O
58	O
,	O
59	O
].	O

The	O
two	O
remaining	O
studies	O
found	O
no	O
association	O
,	O
but	O
these	O
were	O
disregarded	O
since	O
they	O
determined	O
the	O
MCID	O
without	O
differentiating	O
between	O
pain	O
relief	O
and	O
pain	O
worsening	O
[	O
21	O
,	O
45	O
].	O

Six	O
studies	O
assessed	O
the	O
association	O
between	O
baseline	O
pain	O
and	O
relative	O
change	O
and	O
either	O
found	O
the	O
association	O
to	O
be	O
non	O
-	O
significant	O
or	O
found	O
it	O
to	O
be	O
weaker	O
than	O
for	O
absolute	O
change	O
.	O

Based	O
on	O
meta	O
-	O
regression	O
,	O
we	O
found	O
no	O
association	O
between	O
baseline	O
pain	O
and	O
either	O
absolute	O
(	O
20	O
studies	O
,	O
P	O
=	O
0	O
.	O
70	O
)	O
nor	O
relative	O
(	O
9	O
studies	O
,	O
P	O
=	O
0	O
.	O
83	O
)	O
estimates	O
of	O
MCIDs	O
.	O

However	O
,	O
based	O
on	O
individual	O
patient	O
data	O
meta	O
-	O
analysis	O
from	O
seven	O
studies	O
(	O
918	O
patients	O
),	O
we	O
found	O
a	O
strong	O
association	O
between	O
baseline	O
pain	O
and	O
absolute	O
MCID	O
,	O
showing	O
that	O
patients	O
with	O
higher	O
baseline	O
pain	O
need	O
larger	O
pain	O
reduction	O
to	O
reach	O
a	O
minimum	O
clinically	O
relevant	O
difference	O
compared	O
to	O
patients	O
with	O
lower	O
baseline	O
pain	O
.	O

For	O
each	O
10	O
mm	O
increase	O
in	O
baseline	O
pain	O
,	O
MCID	O
increased	O
by	O
3	O
.	O
1	O
mm	O
(	O
95	O
%	O
confidence	O
interval	O
,	O
2	O
.	O
8	O
–	O
3	O
.	O
5	O
mm	O
,	O
P	O
<	O
0	O
.	O
001	O
,	O
I2	O
=	O
0	O
%).	O

Thus	O
,	O
for	O
patients	O
with	O
initial	O
pain	O
levels	O
<	O
40	O
,	O
40	O
–	O
70	O
,	O
and	O
>	O
70	O
mm	O
,	O
the	O
MCIDs	O
were	O
6	O
(	O
4	O
–	O
8	O
)	O
mm	O
,	O
13	O
(	O
11	O
–	O
14	O
)	O
mm	O
,	O
and	O
21	O
(	O
20	O
–	O
23	O
)	O
mm	O
,	O
respectively	O
(	O
Fig	O
.	O
3	O
).	O

The	O
corresponding	O
relative	O
estimates	O
of	O
MCIDs	O
did	O
not	O
differ	O
significantly	O
:	O
17	O
(	O
4	O
–	O
30	O
)	O
%,	O
23	O
(	O
20	O
–	O
25	O
)	O
%,	O
and	O
24	O
(	O
22	O
–	O
26	O
)	O
%,	O
respectively	O
.	O

In	O
contrast	O
,	O
we	O
found	O
that	O
patients	O
with	O
more	O
severe	O
pain	O
perceived	O
worsening	O
of	O
their	O
status	O
with	O
smaller	O
increases	O
of	O
pain	O
intensity	O
:	O
the	O
absolute	O
MCID	O
was	O
2	O
.	O
3	O
mm	O
less	O
for	O
each	O
10	O
mm	O
increase	O
in	O
baseline	O
pain	O
(	O
1	O
.	O
4	O
–	O
3	O
.	O
0	O
,	O
P	O
<	O
0	O
.	O
001	O
,	O
I2	O
=	O
67	O
%).	O
Fig	O
.	O
3Minimum	O
clinically	O
important	O
difference	O
by	O
baseline	O
pain	O
(	O
individual	O
patient	O
data	O
from	O
7	O
studies	O
,	O
918	O
patients	O
).	O

MCID	O
assessed	O
as	O
the	O
mean	O
change	O
in	O
pain	O
score	O
among	O
patients	O
with	O
minimal	O
improvement	O
of	O
pain	O
,	O
MCID	O
=	O
Minimal	O
Clinically	O
Important	O
Difference	O
(	O
mm	O
reduction	O
on	O
a	O
100	O
mm	O
scale	O
).	O

Forest	O
plot	O
of	O
mean	O
pain	O
difference	O
in	O
723	O
episodes	O
where	O
patients	O
reported	O
pain	O
to	O
be	O
“	O
a	O
little	O
better	O
”	O
in	O
7	O
studies	O
including	O
a	O
total	O
of	O
918	O
patients	O

From	O
individual	O
patient	O
data	O
,	O
we	O
also	O
found	O
that	O
the	O
MCID	O
decreased	O
with	O
increasing	O
time	O
from	O
baseline	O
,	O
from	O
17	O
(	O
12	O
to	O
21	O
)	O
mm	O
at	O
30	O
minutes	O
to	O
11	O
(	O
8	O
to	O
14	O
)	O
mm	O
at	O
120	O
minutes	O
.	O

However	O
,	O
patients	O
’	O
pain	O
level	O
declined	O
accordingly	O
during	O
the	O
multiple	O
follow	O
-	O
ups	O
and	O
estimates	O
expressed	O
as	O
a	O
relative	O
change	O
from	O
the	O
previous	O
assessment	O
therefore	O
did	O
not	O
decline	O
.	O

Impact	O
of	O
other	O
clinical	O
and	O
methodological	O
factors	O

Other	O
causes	O
for	O
variation	O
in	O
the	O
MCID	O
were	O
addressed	O
in	O
10	O
studies	O
.	O

These	O
included	O
sex	O
[	O
33	O
,	O
35	O
,	O
36	O
,	O
44	O
–	O
48	O
,	O
51	O
,	O
54	O
,	O
57	O
,	O
59	O
],	O
age	O
[	O
33	O
,	O
35	O
,	O
36	O
,	O
44	O
–	O
46	O
,	O
48	O
,	O
51	O
,	O
54	O
,	O
57	O
,	O
59	O
],	O
education	O
level	O
[	O
35	O
,	O
48	O
,	O
51	O
,	O
54	O
],	O
ethnicity	O
[	O
54	O
,	O
57	O
],	O
primary	O
language	O
(	O
English	O
or	O
Spanish	O
)	O
[	O
57	O
],	O
and	O
religion	O
[	O
54	O
],	O
as	O
well	O
as	O
cause	O
(	O
traumatic	O
or	O
non	O
-	O
traumatic	O
)	O
[	O
44	O
–	O
48	O
,	O
57	O
],	O
duration	O
[	O
35	O
]	O
and	O
location	O
[	O
35	O
]	O
of	O
pain	O
.	O

None	O
of	O
the	O
studies	O
found	O
associations	O
except	O
for	O
one	O
[	O
48	O
],	O
which	O
reported	O
higher	O
MCIDs	O
for	O
men	B-OG
compared	O
to	O
women	B-OG
and	O
for	O
non	O
-	O
traumatic	O
pain	O
compared	O
to	O
traumatic	O
pain	O
.	O

However	O
,	O
these	O
analyses	O
were	O
not	O
adjusted	O
for	O
differences	O
in	O
baseline	O
pain	O
.	O

The	O
MCIDs	O
of	O
subgroups	O
are	O
presented	O
as	O
medians	O
and	O
pooled	O
averages	O
,	O
respectively	O
(	O
Table	O
4	O
).	O

For	O
most	O
clinical	O
and	O
methodological	O
factors	O
,	O
the	O
number	O
of	O
studies	O
in	O
each	O
subgroup	O
was	O
too	O
small	O
to	O
ensure	O
detection	O
of	O
relevant	O
differences	O
between	O
them	O
.	O

Nevertheless	O
,	O
although	O
only	O
few	O
studies	O
defined	O
the	O
MCID	O
as	O
the	O
mean	O
pain	O
reduction	O
among	O
patients	O
with	O
several	O
categories	O
of	O
improvement	O
,	O
or	O
patients	O
with	O
‘	O
meaningful	O
’	O
(	O
and	O
not	O
just	O
‘	O
minimum	O
’)	O
change	O
,	O
it	O
was	O
clear	O
that	O
these	O
studies	O
found	O
higher	O
MCIDs	O
(	O
medians	O
25	O
(	O
IQR	O
23	O
–	O
29	O
)	O
and	O
34	O
(	O
IQR	O
27	O
–	O
40	O
),	O
respectively	O
)	O
than	O
studies	O
where	O
it	O
was	O
defined	O
as	O
the	O
mean	O
pain	O
reduction	O
among	O
patients	O
with	O
a	O
one	O
-	O
category	O
improvement	O
(	O
median	O
16	O
(	O
IQR	O
13	O
–	O
21	O
)).	O

It	O
was	O
also	O
clear	O
that	O
the	O
MCID	O
was	O
higher	O
when	O
based	O
on	O
a	O
single	O
assessment	O
involving	O
one	O
fixed	O
baseline	O
value	O
(	O
median	O
25	O
(	O
IQR	O
23	O
–	O
29	O
)),	O
than	O
when	O
summarised	O
from	O
multiple	O
assessments	O
with	O
the	O
previous	O
assessment	O
applied	O
as	O
a	O
‘	O
moving	O
baseline	O
’	O
(	O
medians	O
15	O
(	O
IQR	O
13	O
–	O
16	O
)	O
and	O
16	O
(	O
IQR	O
10	O
–	O
21	O
),	O
respectively	O
).	O

Subgroups	O
of	O
studies	O
among	O
patients	O
with	O
various	O
clinical	O
conditions	O
were	O
underpowered	O
to	O
detect	O
relevant	O
differences	O
.	O

The	O
comparison	O
of	O
one	O
-	O
and	O
two	O
-	O
sided	O
transition	O
scales	O
was	O
also	O
underpowered	O
,	O
but	O
the	O
difference	O
in	O
scales	O
did	O
not	O
seem	O
to	O
affect	O
study	O
results	O
,	O
while	O
the	O
comparison	O
of	O
VAS	O
and	O
NRS	O
included	O
enough	O
studies	O
to	O
conclude	O
that	O
type	O
of	O
pain	O
scale	O
did	O
not	O
influence	O
the	O
MCID	O
.	O

Finally	O
,	O
we	O
did	O
not	O
find	O
differences	O
in	O
outcomes	O
relating	O
to	O
the	O
risk	O
of	O
attrition	O
bias	O
or	O
risk	O
of	O
non	O
-	O
representative	O
samples	O
.	O
Table	O
4Subgroup	O
analyses	O
of	O
absolute	O
minimum	O
clinically	O
important	O
differences	O
(	O
MCIDs	O
)	O
for	O
pain	O
reliefSubgroupAnalysis	O
of	O
mediansAnalysis	O
of	O
pooled	O
averageRange	O
,	O
mmNumber	O
of	O
studiesa	O
(	O
patientsb	O
)	O
MCID	O
Median	O
,	O
mm	O
(	O
IQR	O
)	O
Number	O
of	O
studies	O
(	O
patientsb	O
)	O
MCID	O
pooled	O
average	O
,	O
mm	O
(	O
95	O
%	O
CI	O
),	O
I2	O
c	O
All	O
studies8	O
–	O
4029	O
(	O
6517	O
)	O
17	O
(	O
14	O
–	O
23	O
)	O
23	O
(	O
6024	O
)	O
17	O
(	O
15	O
–	O
19	O
),	O
93	O
%	O
Clinical	O
conditions	O
Post	O
-	O
operation	O
paind	O
9	O
–	O
297	O
(	O
731	O
)	O
18	O
(	O
10	O
–	O
25	O
)	O
3	O
(	O
361	O
)	O
11	O
(	O
8	O
–	O
14	O
),	O
42	O
%	O
Trauma16	O
–	O
202	O
(	O
125	O
)	O
18	O
(	O
16	O
–	O
20	O
)	O
2	O
(	O
125	O
)	O
18	O
(	O
15	O
–	O
22	O
),	O
11	O
%	O
Abdominal	O
pain18	O
–	O
252	O
(	O
407	O
)	O
21	O
(	O
18	O
–	O
25	O
)	O
2	O
(	O
407	O
)	O
21	O
(	O
15	O
–	O
28	O
),	O
91	O
%	O
Mixed	O
patients	O
at	O
ED8	O
–	O
247	O
(	O
2418	O
)	O
15	O
(	O
11	O
–	O
21	O
)	O
6	O
(	O
2345	O
)	O
16	O
(	O
12	O
–	O
20	O
),	O
90	O
%	O
Othere	O
10	O
–	O
405	O
(	O
1980	O
)	O
27	O
(	O
23	O
–	O
34	O
)	O
4	O
(	O
1930	O
)	O
22	O
(	O
15	O
–	O
29	O
),	O
92	O
%	O
Unspecified13	O
–	O
216	O
(	O
856	O
)	O
16	O
(	O
14	O
–	O
16	O
)	O
6	O
(	O
856	O
)	O
16	O
(	O
14	O
–	O
18	O
),	O
72	O
%	O
Definition	O
of	O
MCID	O
One	O
category	O
improvement8	O
–	O
3424	O
(	O
4504	O
)	O
16	O
(	O
13	O
–	O
21	O
)	O
22	O
(	O
4281	O
)	O
16	O
(	O
14	O
–	O
18	O
),	O
91	O
%	O
Several	O
categories	O
improvement23	O
–	O
293	O
(	O
220	O
)	O
25	O
(	O
23	O
–	O
29	O
)	O
NANA	O
Meaningful	O
change27	O
–	O
402	O
(	O
1793	O
)	O
34	O
(	O
27	O
–	O
40	O
)	O
1	O
(	O
1743	O
)	O
27	O
(	O
25	O
–	O
29	O
),	O
NADirectionality	O
of	O
transition	O
scale	O
One	O
-	O
sided9	O
–	O
405	O
(	O
538	O
)	O
18	O
(	O
13	O
–	O
21	O
)	O
3	O
(	O
383	O
)	O
15	O
(	O
8	O
–	O
21	O
),	O
93	O
%	O
Two	O
-	O
sided8	O
–	O
2519	O
(	O
3962	O
)	O
16	O
(	O
13	O
–	O
20	O
)	O
18	O
(	O
3844	O
)	O
16	O
(	O
14	O
–	O
19	O
),	O
91	O
%	O
Pain	O
scale	O
Visual	O
Analogue	O
Scale8	O
–	O
4017	O
(	O
3232	O
)	O
17	O
(	O
13	O
–	O
25	O
)	O
15	O
(	O
3109	O
)	O
16	O
(	O
13	O
–	O
19	O
),	O
91	O
%	O
Numeric	O
Rating	O
Scale10	O
–	O
237	O
(	O
1268	O
)	O
15	O
(	O
14	O
–	O
21	O
)	O
6	O
(	O
1118	O
)	O
16	O
(	O
14	O
–	O
19	O
),	O
91	O
%	O
Measurements	O
per	O
patient	O
Single18	O
–	O
404	O
(	O
461	O
)	O
25	O
(	O
23	O
–	O
29	O
)	O
4	O
(	O
2058	O
)	O
22	O
(	O
19	O
–	O
25	O
),	O
0	O
%	O
Multiple	O
With	O
adjustment10	O
–	O
189	O
(	O
1104	O
)	O
15	O
(	O
13	O
–	O
16	O
)	O
8	O
(	O
1031	O
)	O
15	O
(	O
13	O
–	O
16	O
),	O
34	O
%	O
Without	O
Adjustment	O
/	O
unclear8	O
–	O
2511	O
(	O
2935	O
)	O
16	O
(	O
10	O
–	O
21	O
)	O
11	O
(	O
2935	O
)	O
16	O
(	O
13	O
–	O
20	O
),	O
95	O
%	O
Risk	O
of	O
attrition	O
bias	O
Low8	O
–	O
408	O
(	O
1249	O
)	O
19	O
(	O
15	O
–	O
25	O
)	O
8	O
(	O
1249	O
)	O
16	O
(	O
14	O
–	O
18	O
),	O
81	O
%	O
High	O
or	O
unclear9	O
–	O
2516	O
(	O
3251	O
)	O
16	O
(	O
12	O
–	O
19	O
)	O
13	O
(	O
2978	O
)	O
16	O
(	O
13	O
–	O
19	O
),	O
93	O
%	O
Risk	O
of	O
non	O
-	O
representative	O
sampling	O
Low8	O
–	O
256	O
(	O
1187	O
)	O
16	O
(	O
10	O
–	O
21	O
)	O
6	O
(	O
1187	O
)	O
16	O
(	O
11	O
–	O
21	O
),	O
96	O
%	O
High	O
or	O
unclear9	O
–	O
4018	O
(	O
3313	O
)	O
18	O
(	O
14	O
–	O
24	O
)	O
15	O
(	O
3040	O
)	O
16	O
(	O
14	O
–	O
18	O
),	O
87	O
%	O
IQR	O
inter	O
-	O
quartile	O
range	O
,	O
ED	O
Emergency	O
department	O
,	O
NA	O
not	O
applicable	O
aThe	O
median	O
is	O
based	O
on	O
studies	O
included	O
in	O
the	O
pooled	O
average	O
as	O
well	O
as	O
studies	O
with	O
unavailable	O
standard	O
errors	O
bTotal	O
number	O
of	O
patients	O
in	O
studies	O
cI2	O
is	O
the	O
percentage	O
of	O
the	O
variability	O
in	O
results	O
that	O
is	O
due	O
to	O
heterogeneity	O
rather	O
than	O
sampling	O
error	O
(	O
chance	O
);	O
I2	O
of	O
0	O
%	O
to	O
40	O
%	O
might	O
not	O
be	O
important	O
,	O
30	O
%	O
to	O
60	O
%	O
may	O
represent	O
moderate	O
heterogeneity	O
,	O
50	O
%	O
to	O
90	O
%	O
may	O
represent	O
substantial	O
heterogeneity	O
,	O
and	O
75	O
%	O
to	O
100	O
%	O
represents	O
considerable	O
heterogeneity	O
dIncludes	O
knee	O
surgery	O
,	O
laparotomy	O
,	O
third	O
molar	O
extraction	O
and	O
mixed	O
surgery	O
(	O
e	O
.	O
g	O
.	O
spinal	O
fusion	O
and	O
splenectomy	O
)	O
eIncludes	O
headache	O
,	O
low	O
back	O
pain	O
,	O
sickle	B-DS
cell	I-DS
crisis	I-DS
,	O
rheumatic	O
condition	O
,	O
and	O
pain	O
flare	O
after	O
external	O
beam	O
radiotherapy	O
for	O
bone	B-DS
metastases	I-DS

Supplementary	O
outcomes	O

The	O
supplementary	O
outcomes	O
for	O
pain	O
relief	O
and	O
worsening	O
were	O
only	O
reported	O
from	O
studies	O
using	O
the	O
mean	O
change	O
approach	O
(	O
Table	O
3	O
).	O

The	O
results	O
showed	O
similarly	O
high	O
heterogeneity	O
.	O

The	O
substantial	O
clinically	O
important	O
difference	O
for	O
pain	O
relief	O
ranged	O
from	O
18	O
to	O
54	O
mm	O
(	O
23	O
studies	O
),	O
while	O
minimum	O
and	O
substantial	O
clinically	O
important	O
differences	O
for	O
worsening	O
of	O
pain	O
ranged	O
from	O
8	O
to	O
21	O
mm	O
increase	O
(	O
18	O
studies	O
)	O
and	O
from	O
0	O
to	O
66	O
mm	O
increase	O
(	O
16	O
studies	O
),	O
respectively	O
.	O

Discussion	O

We	O
included	O
37	O
studies	O
(	O
8479	O
patients	O
)	O
assessing	O
the	O
MCID	O
in	O
acute	O
pain	O
,	O
of	O
which	O
35	O
used	O
the	O
mean	O
change	O
approach	O
and	O
seven	O
used	O
the	O
threshold	O
approach	O
.	O

Meta	O
-	O
analyses	O
found	O
considerable	O
heterogeneity	O
between	O
studies	O
and	O
,	O
consequently	O
,	O
no	O
single	O
value	O
of	O
minimum	O
clinical	O
important	O
difference	O
could	O
be	O
meaningfully	O
determined	O
.	O

Study	O
results	O
ranged	O
widely	O
both	O
when	O
they	O
were	O
reported	O
as	O
absolute	O
change	O
(	O
from	O
8	O
to	O
40	O
mm	O
)	O
and	O
as	O
relative	O
change	O
from	O
baseline	O
(	O
from	O
13	O
to	O
85	O
%).	O

The	O
median	O
of	O
study	O
results	O
based	O
on	O
the	O
mean	O
change	O
approach	O
was	O
17	O
(	O
IQR	O
14	O
to	O
23	O
)	O
mm	O
and	O
23	O
(	O
IQR	O
18	O
to	O
36	O
)	O
%	O
for	O
absolute	O
and	O
relative	O
values	O
,	O
respectively	O
.	O

Reasons	O
for	O
heterogeneity	O
were	O
explored	O
and	O
baseline	O
pain	O
was	O
identified	O
as	O
a	O
cause	O
of	O
variation	O
in	O
absolute	O
,	O
but	O
not	O
relative	O
,	O
outcomes	O
.	O

In	O
addition	O
,	O
the	O
definition	O
of	O
minimum	O
clinically	O
important	O
change	O
and	O
the	O
use	O
of	O
multiple	O
assessments	O
per	O
patient	O
influenced	O
study	O
results	O
.	O

High	O
heterogeneity	O
was	O
also	O
found	O
for	O
assessments	O
of	O
substantial	O
clinically	O
important	O
difference	O
as	O
well	O
as	O
for	O
worsening	O
of	O
pain	O
.	O

Strengths	O
and	O
limitations	O

To	O
our	O
knowledge	O
,	O
this	O
is	O
the	O
first	O
systematic	O
review	O
of	O
MCIDs	O
in	O
acute	O
pain	O
.	O

We	O
identified	O
37	O
studies	O
involving	O
over	O
8000	O
patients	O
and	O
a	O
broad	O
range	O
of	O
clinical	O
conditions	O
,	O
study	O
approaches	O
and	O
pain	O
scales	O
.	O

We	O
gained	O
access	O
to	O
unpublished	O
data	O
from	O
10	O
studies	O
,	O
including	O
individual	O
patient	O
data	O
from	O
seven	O
studies	O
(	O
918	O
patients	O
).	O

This	O
ensured	O
high	O
data	O
quality	O
and	O
uniform	O
analysis	O
,	O
and	O
enabled	O
an	O
adequate	O
assessment	O
of	O
the	O
association	O
with	O
baseline	O
pain	O
avoiding	O
the	O
risk	O
of	O
ecological	O
fallacy	O
[	O
24	O
]	O
inherent	O
to	O
aggregated	O
study	O
-	O
level	O
data	O
.	O

The	O
median	O
results	O
of	O
studies	O
providing	O
individual	O
patient	O
data	O
was	O
comparable	O
with	O
the	O
remaining	O
studies	O
and	O
we	O
have	O
no	O
reason	O
to	O
believe	O
these	O
studies	O
were	O
not	O
representative	O
.	O

Association	O
with	O
baseline	O
pain	O
has	O
been	O
reported	O
from	O
individual	O
studies	O
[	O
31	O
,	O
33	O
,	O
36	O
,	O
43	O
,	O
57	O
–	O
59	O
],	O
but	O
the	O
present	O
review	O
is	O
the	O
first	O
comprehensive	O
assessment	O
of	O
the	O
impact	O
of	O
baseline	O
pain	O
across	O
studies	O
.	O

In	O
addition	O
,	O
we	O
identified	O
variation	O
in	O
study	O
designs	O
(	O
single	O
or	O
multiple	O
assessments	O
)	O
and	O
definitions	O
of	O
patients	O
with	O
minimum	O
relief	O
as	O
factors	O
influencing	O
the	O
MCID	O
.	O

However	O
,	O
we	O
were	O
not	O
able	O
to	O
fully	O
explain	O
the	O
large	O
heterogeneity	O
among	O
studies	O
.	O

We	O
found	O
no	O
effects	O
of	O
pain	O
scale	O
,	O
but	O
for	O
the	O
comparison	O
of	O
clinical	O
conditions	O
and	O
directionality	O
of	O
transition	O
scale	O
,	O
subgroups	O
involved	O
too	O
few	O
studies	O
to	O
ensure	O
detection	O
of	O
all	O
relevant	O
associations	O
.	O

In	O
addition	O
,	O
our	O
ability	O
to	O
assess	O
clinical	O
condition	O
was	O
limited	O
by	O
the	O
fact	O
that	O
many	O
studies	O
included	O
a	O
mixed	O
patient	O
group	O
and	O
we	O
did	O
not	O
have	O
access	O
to	O
individual	O
patient	O
diagnoses	O
.	O

Similarly	O
,	O
the	O
studies	O
included	O
a	O
variety	O
of	O
analgesia	O
and	O
other	O
treatments	O
which	O
did	O
not	O
allow	O
an	O
assessment	O
of	O
potential	O
impact	O
of	O
interventions	O
.	O

Regarding	O
the	O
risk	O
of	O
attrition	O
bias	O
and	O
non	O
-	O
representative	O
sampling	O
,	O
the	O
majority	O
of	O
studies	O
were	O
categorised	O
as	O
unclear	O
and	O
potential	O
impact	O
could	O
therefore	O
not	O
be	O
assessed	O
.	O

Most	O
importantly	O
,	O
acknowledging	O
the	O
association	O
with	O
baseline	O
pain	O
,	O
it	O
would	O
have	O
been	O
more	O
accurate	O
to	O
base	O
subgroup	O
analyses	O
on	O
relative	O
outcomes	O
,	O
but	O
the	O
data	O
available	O
only	O
allowed	O
comparison	O
of	O
absolute	O
outcomes	O
.	O

We	O
could	O
not	O
assess	O
impact	O
of	O
various	O
description	O
of	O
pain	O
(	O
e	O
.	O
g	O
.	O
“	O
intensity	O
”)	O
or	O
the	O
follow	O
-	O
up	O
time	O
between	O
measurements	O
since	O
there	O
was	O
not	O
enough	O
variation	O
between	O
studies	O
.	O

Furthermore	O
,	O
the	O
available	O
data	O
did	O
not	O
allow	O
an	O
assessment	O
of	O
the	O
potential	O
influence	O
of	O
pre	O
-	O
existing	O
pain	O
level	O
(	O
e	O
.	O
g	O
.	O
if	O
patients	O
are	O
affected	O
by	O
chronic	O
pain	O
in	O
addition	O
to	O
their	O
current	O
episode	O
of	O
acute	O
pain	O
),	O
pre	O
-	O
existing	O
use	O
of	O
pain	O
relief	O
or	O
the	O
psychological	O
state	O
of	O
patients	O
,	O
since	O
this	O
was	O
not	O
reported	O
by	O
any	O
of	O
the	O
studies	O
.	O

Finally	O
,	O
we	O
cannot	O
dismiss	O
the	O
risk	O
of	O
recall	O
bias	O
in	O
studies	O
where	O
patients	O
simultaneously	O
assess	O
their	O
pain	O
status	O
and	O
perceived	O
change	O
[	O
60	O
].	O

Differences	O
in	O
baseline	O
pain	O
or	O
other	O
methodological	O
or	O
clinical	O
factors	O
may	O
influence	O
subgroup	O
analyses	O
of	O
study	O
-	O
level	O
data	O
.	O

Thus	O
,	O
better	O
access	O
to	O
individual	O
patient	O
data	O
would	O
greatly	O
improve	O
the	O
chances	O
of	O
identifying	O
causes	O
of	O
heterogeneity	O
.	O

Other	O
studies	O

Only	O
few	O
systematic	O
reviews	O
of	O
the	O
minimum	O
clinically	O
relevant	O
change	O
have	O
been	O
published	O
despite	O
a	O
vast	O
number	O
of	O
primary	O
studies	O
.	O

Stauffer	O
[	O
20	O
]	O
and	O
Erdogan	O
[	O
61	O
]	O
reviewed	O
studies	O
of	O
minimum	O
clinically	O
relevant	O
change	O
in	O
pain	O
scales	O
used	O
for	O
chronic	O
rheumatologic	O
conditions	O
,	O
but	O
we	O
have	O
not	O
identified	O
any	O
systematic	O
reviews	O
focusing	O
on	O
acute	O
pain	O
.	O

The	O
problem	O
of	O
variability	O
in	O
results	O
of	O
studies	O
of	O
minimum	O
clinically	O
relevant	O
change	O
has	O
previously	O
been	O
addressed	O
primarily	O
when	O
attempting	O
to	O
reconcile	O
dissimilar	O
results	O
from	O
different	O
approaches	O
,	O
e	O
.	O
g	O
.	O
anchor	O
-	O
based	O
and	O
distribution	O
-	O
based	O
studies	O
[	O
62	O
].	O

Our	O
study	O
demonstrates	O
considerable	O
unexplained	O
variation	O
also	O
within	O
anchor	O
-	O
based	O
approaches	O
.	O

In	O
line	O
with	O
our	O
findings	O
,	O
Terwee	O
[	O
63	O
]	O
found	O
variability	O
between	O
results	O
of	O
five	O
studies	O
of	O
minimum	O
clinically	O
important	O
change	O
on	O
the	O
Western	O
Ontario	O
and	O
McMaster	O
University	O
pain	O
subscale	O
for	O
osteoarthritis	B-DS
.	O

In	O
a	O
systematic	O
review	O
of	O
the	O
minimum	O
clinical	O
important	O
difference	O
in	O
chronic	O
pain	O
,	O
we	O
have	O
found	O
similar	O
issues	O
of	O
high	O
study	O
variability	O
(	O
manuscript	O
in	O
preparation	O
).	O

Mechanisms	O
and	O
perspectives	O

We	O
included	O
studies	O
with	O
a	O
patient	O
-	O
reported	O
anchor	O
.	O

While	O
some	O
find	O
that	O
using	O
a	O
patient	O
-	O
reported	O
criterion	O
as	O
an	O
anchor	O
for	O
a	O
patient	O
-	O
reported	O
score	O
is	O
circular	O
and	O
basically	O
flawed	O
[	O
64	O
],	O
we	O
would	O
argue	O
that	O
pain	O
intensity	O
is	O
essentially	O
a	O
subjective	O
experience	O
best	O
expressed	O
by	O
and	O
anchored	O
to	O
those	O
experiencing	O
it	O
.	O

Other	O
observer	O
-	O
based	O
anchors	O
may	O
be	O
used	O
when	O
the	O
outcome	O
of	O
interest	O
is	O
return	O
to	O
work	O
or	O
daily	O
level	O
of	O
activity	O
[	O
65	O
].	O

The	O
varying	O
content	O
of	O
the	O
patient	O
-	O
reported	O
anchors	O
is	O
,	O
however	O
,	O
problematic	O
.	O

The	O
applied	O
transition	O
scales	O
were	O
either	O
one	O
-	O
or	O
two	O
-	O
sided	O
,	O
allowing	O
patients	O
to	O
report	O
their	O
degree	O
of	O
change	O
(	O
or	O
only	O
relief	O
)	O
by	O
choosing	O
between	O
anywhere	O
from	O
three	O
to	O
15	O
response	O
categories	O
.	O

The	O
majority	O
of	O
studies	O
then	O
determined	O
the	O
MCID	O
as	O
a	O
mean	O
change	O
in	O
pain	O
score	O
among	O
everyone	O
reporting	O
a	O
one	O
-	O
category	O
pain	O
relief	O
.	O

However	O
,	O
this	O
value	O
does	O
not	O
apply	O
to	O
all	O
individuals	O
in	O
the	O
group	O
,	O
since	O
their	O
differences	O
in	O
pain	O
are	O
distributed	O
around	O
the	O
mean	O
[	O
14	O
].	O

In	O
contrast	O
,	O
MCIDs	O
expressed	O
as	O
threshold	O
values	O
are	O
derived	O
with	O
the	O
intention	O
of	O
obtaining	O
the	O
best	O
possible	O
discrimination	O
between	O
patients	O
with	O
and	O
without	O
relevant	O
relief	O
.	O

The	O
frequency	O
of	O
false	O
-	O
positive	O
and	O
false	O
-	O
negative	O
results	O
may	O
be	O
reduced	O
but	O
is	O
not	O
eliminated	O
by	O
this	O
approach	O
.	O

Therefore	O
,	O
caution	O
is	O
always	O
merited	O
when	O
bringing	O
an	O
overall	O
estimate	O
of	O
important	O
change	O
to	O
the	O
level	O
of	O
interpretation	O
for	O
an	O
individual	O
patient	O
[	O
66	O
,	O
67	O
].	O

The	O
studies	O
we	O
included	O
varied	O
considerably	O
both	O
in	O
methods	O
and	O
analytical	O
approaches	O
.	O

As	O
would	O
be	O
expected	O
,	O
differences	O
in	O
the	O
definition	O
of	O
patients	O
with	O
minimum	O
important	O
change	O
impacted	O
study	O
results	O
.	O

We	O
also	O
found	O
that	O
the	O
use	O
of	O
multiple	O
measurements	O
per	O
patient	O
resulted	O
in	O
lower	O
outcomes	O
.	O

This	O
corresponded	O
with	O
the	O
finding	O
that	O
outcomes	O
decreased	O
during	O
several	O
follow	O
-	O
ups	O
as	O
patients	O
’	O
pain	O
declined	O
over	O
time	O
.	O

Furthermore	O
,	O
one	O
in	O
four	O
of	O
the	O
reviewed	O
studies	O
did	O
not	O
differentiate	O
between	O
minimum	O
relief	O
and	O
minimum	O
worsening	O
of	O
pain	O
in	O
their	O
original	O
study	O
reports	O
.	O

The	O
practice	O
of	O
combining	O
groups	O
with	O
minimum	O
change	O
,	O
regardless	O
of	O
its	O
direction	O
,	O
is	O
sometimes	O
based	O
on	O
a	O
seemingly	O
similar	O
distribution	O
of	O
data	O
in	O
the	O
two	O
groups	O
[	O
44	O
].	O

However	O
,	O
although	O
they	O
may	O
be	O
similar	O
at	O
one	O
point	O
,	O
the	O
MCID	O
for	O
pain	O
relief	O
and	O
worsening	O
will	O
change	O
in	O
opposite	O
directions	O
with	O
variations	O
of	O
baseline	O
pain	O
(	O
since	O
patients	O
with	O
higher	O
baseline	O
pain	O
require	O
larger	O
pain	O
reduction	O
to	O
perceive	O
relief	O
,	O
but	O
smaller	O
increase	O
to	O
perceive	O
worsening	O
of	O
their	O
condition	O
).	O

The	O
association	O
between	O
MCID	O
and	O
baseline	O
pain	O
may	O
to	O
some	O
extent	O
be	O
explained	O
by	O
‘	O
regression	O
towards	O
the	O
mean	O
’	O
as	O
patients	O
are	O
likely	O
to	O
score	O
closer	O
to	O
the	O
mean	O
if	O
their	O
initial	O
scores	O
were	O
more	O
extreme	O
because	O
of	O
chance	O
[	O
68	O
].	O

However	O
,	O
it	O
is	O
also	O
very	O
plausible	O
that	O
patients	O
with	O
higher	O
pain	O
require	O
greater	O
decrease	O
to	O
perceive	O
relief	O
.	O

Relative	O
changes	O
are	O
therefore	O
more	O
stable	O
indicators	O
of	O
clinically	O
important	O
differences	O
,	O
although	O
they	O
lack	O
interval	O
scale	O
properties	O
at	O
the	O
scale	O
extremes	O
,	O
e	O
.	O
g	O
.	O
when	O
baseline	O
values	O
are	O
close	O
to	O
zero	O
and	O
small	O
degrees	O
of	O
pain	O
change	O
result	O
in	O
very	O
large	O
relative	O
changes	O
[	O
69	O
].	O

From	O
this	O
review	O
,	O
however	O
,	O
it	O
is	O
clear	O
that	O
the	O
advantage	O
of	O
relative	O
values	O
is	O
largely	O
overlooked	O
,	O
since	O
only	O
10	O
of	O
37	O
studies	O
(	O
27	O
%)	O
reported	O
relative	O
change	O
.	O

This	O
review	O
included	O
studies	O
that	O
determined	O
MCID	O
from	O
an	O
anchor	O
-	O
based	O
method	O
using	O
patients	O
’	O
perception	O
of	O
change	O
to	O
determine	O
clinical	O
importance	O
.	O

Although	O
this	O
is	O
the	O
most	O
common	O
approach	O
,	O
it	O
is	O
just	O
one	O
among	O
a	O
wide	O
range	O
of	O
alternative	O
methods	O
.	O

Revicki	O
noted	O
that	O
retrospective	O
self	O
-	O
reports	O
of	O
pain	O
relief	O
tend	O
to	O
correlate	O
more	O
strongly	O
with	O
the	O
end	O
-	O
level	O
of	O
pain	O
than	O
the	O
start	O
level	O
,	O
implying	O
that	O
the	O
current	O
status	O
matters	O
to	O
patients	O
more	O
than	O
the	O
degree	O
of	O
improvement	O
[	O
70	O
].	O

This	O
has	O
led	O
to	O
the	O
development	O
of	O
the	O
concept	O
of	O
‘	O
patient	O
acceptable	O
symptom	O
state	O
’,	O
defined	O
as	O
the	O
level	O
of	O
symptoms	O
which	O
patients	O
feel	O
is	O
acceptable	O
[	O
71	O
,	O
72	O
].	O

Patient	O
acceptable	O
symptom	O
state	O
corresponds	O
with	O
the	O
dominant	O
aim	O
of	O
clinical	O
patient	O
care	O
to	O
reduce	O
pain	O
to	O
an	O
acceptable	O
level	O
[	O
73	O
]	O
and	O
could	O
be	O
a	O
strong	O
candidate	O
for	O
an	O
alternative	O
to	O
MCID	O
.	O

Other	O
promising	O
approaches	O
have	O
integrated	O
intervention	O
costs	O
and	O
side	O
effects	O
[	O
74	O
–	O
77	O
].	O

It	O
is	O
likely	O
that	O
the	O
challenges	O
of	O
MCID	O
,	O
apparent	O
for	O
acute	O
pain	O
,	O
may	O
not	O
be	O
isolated	O
to	O
that	O
specific	O
research	O
area	O
.	O

Acute	O
pain	O
stands	O
out	O
because	O
of	O
the	O
many	O
studies	O
that	O
have	O
been	O
conducted	O
,	O
reflecting	O
the	O
status	O
of	O
acute	O
pain	O
as	O
a	O
core	O
symptom	O
in	O
clinical	O
practice	O
.	O

Our	O
study	O
can	O
thus	O
be	O
seen	O
as	O
a	O
model	O
for	O
a	O
more	O
general	O
challenge	O
with	O
empirical	O
assessments	O
of	O
the	O
MCID	O
.	O

The	O
methodological	O
challenges	O
embedded	O
in	O
the	O
empirical	O
assessment	O
of	O
MCID	O
are	O
of	O
such	O
an	O
extent	O
that	O
merits	O
caution	O
for	O
its	O
use	O
and	O
interpretation	O
.	O

It	O
is	O
clearly	O
inappropriate	O
to	O
use	O
and	O
interpret	O
MCID	O
as	O
a	O
kind	O
of	O
clinical	O
scale	O
constant	O
–	O
a	O
characteristic	O
which	O
,	O
once	O
empirically	O
determined	O
,	O
is	O
universally	O
valid	O
.	O

This	O
is	O
,	O
however	O
,	O
often	O
the	O
practice	O
seen	O
[	O
78	O
].	O

Nevertheless	O
,	O
there	O
is	O
a	O
strong	O
and	O
reasonable	O
demand	O
for	O
a	O
structured	O
approach	O
for	O
evaluating	O
whether	O
effects	O
of	O
interventions	O
are	O
clinically	O
meaningful	O
to	O
patients	O
.	O

Implications	O

The	O
choice	O
of	O
a	O
reference	O
value	O
has	O
large	O
consequences	O
for	O
the	O
number	O
of	O
patients	O
needed	O
in	O
a	O
trial	O
,	O
e	O
.	O
g	O
.	O
four	O
times	O
as	O
many	O
patients	O
will	O
be	O
included	O
,	O
if	O
researchers	O
accept	O
a	O
MCID	O
value	O
of	O
12	O
mm	O
as	O
compared	O
to	O
24	O
mm	O
.	O

Further	O
,	O
the	O
conclusion	O
about	O
the	O
clinical	O
relevance	O
of	O
a	O
trial	O
result	O
is	O
often	O
based	O
on	O
whether	O
a	O
mean	O
difference	O
exceeds	O
a	O
chosen	O
reference	O
value	O
,	O
but	O
with	O
the	O
large	O
span	O
of	O
MCIDs	O
available	O
in	O
the	O
literature	O
,	O
it	O
is	O
highly	O
problematic	O
to	O
randomly	O
pick	O
one	O
or	O
a	O
few	O
single	O
assessments	O
for	O
guidance	O
.	O

The	O
considerable	O
variation	O
means	O
that	O
it	O
is	O
necessary	O
to	O
conscientiously	O
and	O
explicitly	O
reflect	O
on	O
the	O
span	O
of	O
results	O
in	O
relation	O
to	O
context	O
-	O
specific	O
clinical	O
and	O
methodological	O
factors	O
,	O
as	O
presented	O
in	O
this	O
review	O
,	O
with	O
a	O
particular	O
focus	O
of	O
the	O
baseline	O
pain	O
of	O
patients	O
,	O
whether	O
repeated	O
measurements	O
were	O
used	O
,	O
and	O
how	O
minimum	O
relief	O
was	O
defined	O
.	O

A	O
starting	O
point	O
for	O
such	O
an	O
exercise	O
by	O
individual	O
clinicians	O
or	O
researchers	O
,	O
or	O
by	O
consensus	O
building	O
committees	O
,	O
could	O
very	O
well	O
be	O
our	O
overview	O
of	O
studies	O
and	O
their	O
results	O
.	O

In	O
future	O
studies	O
there	O
is	O
a	O
clear	O
need	O
for	O
uniform	O
guidelines	O
for	O
standardised	O
conduct	O
,	O
analyses	O
and	O
reporting	O
of	O
the	O
MCID	O
,	O
especially	O
for	O
how	O
transition	O
scales	O
and	O
questions	O
are	O
structured	O
and	O
how	O
data	O
are	O
analysed	O
.	O

We	O
strongly	O
encourage	O
using	O
values	O
relative	O
to	O
baseline	O
pain	O
–	O
also	O
for	O
multiple	O
measurements	O
where	O
the	O
patient	O
’	O
s	O
last	O
assessment	O
should	O
be	O
applied	O
as	O
a	O
‘	O
moving	O
baseline	O
’,	O
standardising	O
the	O
definition	O
of	O
relevant	O
pain	O
relief	O
,	O
and	O
distinguishing	O
clearly	O
between	O
improvement	O
and	O
worsening	O
of	O
pain	O
.	O

In	O
addition	O
,	O
since	O
the	O
influence	O
of	O
clinical	O
and	O
methodological	O
factors	O
is	O
difficult	O
to	O
identify	O
from	O
aggregated	O
data	O
,	O
we	O
encourage	O
improved	O
access	O
to	O
individual	O
patient	O
data	O
to	O
enable	O
further	O
exploration	O
of	O
the	O
causes	O
of	O
heterogeneity	O
.	O

Conclusion	O

The	O
MCID	O
in	O
acute	O
pain	O
varied	O
greatly	O
between	O
studies	O
.	O

Absolute	O
MCID	O
ranged	O
from	O
8	O
to	O
40	O
mm	O
in	O
29	O
studies	O
,	O
and	O
relative	O
values	O
ranged	O
from	O
13	O
%	O
to	O
85	O
%	O
in	O
14	O
studies	O
.	O

Baseline	O
pain	O
was	O
strongly	O
associated	O
with	O
absolute	O
,	O
but	O
not	O
relative	O
,	O
values	O
and	O
variation	O
in	O
definitions	O
of	O
minimum	O
relief	O
and	O
study	O
designs	O
influenced	O
study	O
results	O
.	O

Due	O
to	O
the	O
heterogeneity	O
between	O
study	O
results	O
,	O
no	O
meaningful	O
overall	O
value	O
of	O
minimum	O
clinically	O
important	O
change	O
can	O
be	O
concluded	O
.	O

Instead	O
,	O
we	O
recommend	O
that	O
MCIDs	O
are	O
considered	O
context	O
-	O
specific	O
and	O
take	O
account	O
of	O
baseline	O
pain	O
.	O

The	O
MCID	O
in	O
acute	O
pain	O
is	O
central	O
for	O
the	O
interpretation	O
of	O
results	O
of	O
randomised	O
trials	O
and	O
meta	O
-	O
analyses	O
and	O
for	O
determining	O
appropriate	O
sample	O
sizes	O
for	O
new	O
trials	O
,	O
but	O
it	O
is	O
potentially	O
misguiding	O
if	O
determined	O
,	O
applied	O
or	O
interpreted	O
inappropriately	O
.	O

Explicit	O
and	O
conscientious	O
reflections	O
on	O
the	O
choice	O
of	O
a	O
MCID	O
value	O
are	O
required	O
,	O
when	O
using	O
it	O
to	O
classify	O
research	O
results	O
as	O
clinically	O
important	O
or	O
trivial	O
.	O

Relationship	O
between	O
baseline	O
pain	O
and	O
the	O
minimum	O
clinically	O
important	O
differencea	O

Study	O

Subgroups	O
by	O
baseline	O
pain	O
,	O
mm	O

Absolute	O
MCID	O
mm	O
(	O
95	O
%	O
CI	O
)	O

Relative	O
MCID	O
%	O
(	O
95	O
%	O
CI	O
)	O

Studies	O
assessing	O
MCID	O
stratified	O
by	O
baseline	O
pain	O

Stahmer	O
[	O
55	O
]	O

≤	O
50	O
>	O
50	O

NRNR	O

25	O
(	O
SE	O
:	O
10	O
)	O
b	O
35	O
(	O
SE	O
:	O
6	O
)	O
b	O

Voepel	O
-	O
Lewis	O
[	O
59	O
]	O

<	O
50	O
≥	O
50	O

0	O
(−	O
30	O
to	O
20	O
)	O
20	O
(	O
13	O
to	O
25	O
)	O

NRNR	O

Bird	O
[	O
31	O
]	O

<	O
3434	O
–	O
66	O
>	O
66	O

11	O
(	O
7	O
to	O
15	O
)	O
17	O
(	O
13	O
to	O
21	O
)	O
30	O
(	O
17	O
to	O
43	O
)	O

NRNRNR	O

Cepeda	O
[	O
33	O
]	O

Moderate	O
(	O
median	O
:	O
60	O
)	O
Severe	O
(	O
median	O
:	O
80	O
)	O

13	O
(	O
12	O
to	O
14	O
)	O
18	O
(	O
17	O
to	O
19	O
)	O

20	O
(	O
18	O
to	O
22	O
)	O
20	O
(	O
19	O
to	O
22	O
)	O

Tsze	O
[	O
57	O
]	O

<	O
4040	O
–	O
69	O
≥	O
70	O

NRNRNR	O

13	O
(	O
0	O
to	O
29	O
)	O
16	O
(	O
10	O
to	O
23	O
)	O
18	O
(	O
11	O
to	O
29	O
)	O

Tubach	O
[	O
58	O
]	O

Low	O
(	O
mean	O
:	O
55	O
)	O
Intermediate	O
(	O
mean	O
:	O
70	O
)	O
High	O
(	O
mean	O
:	O
85	O
)	O

34	O
(	O
29	O
to	O
38	O
)	O
c	O
45c	O
63	O
(	O
54	O
to	O
68	O
)	O
c	O

NRNRNR	O

Studies	O
assessing	O
correlation	O
between	O
MCID	O
and	O
baseline	O
pain	O

Barton	O
2002	O
(	O
reported	O
in	O
Jensen	O
2002	O
[	O
43	O
])	O

Correlation	O
with	O
baseline	O
pain	O

0	O
.	O
48	O
(	O
P	O
<	O
0	O
.	O
001	O
)	O

0	O
.	O
35	O
(	O
P	O
<	O
0	O
.	O
01	O
)	O

Rasmussen	O
2002	O
(	O
reported	O
in	O
Jensen	O
2002	O
[	O
43	O
])	O

Correlation	O
with	O
baseline	O
pain	O

0	O
.	O
52	O
(	O
P	O
<	O
0	O
.	O
001	O
)	O

0	O
.	O
34	O
(	O
P	O
<	O
0	O
.	O
01	O
)	O

Farrar	O
[	O
36	O
]	O

Correlation	O
with	O
baseline	O
pain	O

Patients	O
with	O
higher	O
baseline	O
pain	O
reported	O
greater	O
relief	O
(	O
e	O
.	O
g	O
.	O
90	O
vs	O
.	O
40	O
mm	O
,	O
P	O
=	O
0	O
.	O
048	O
)	O

No	O
significant	O
differences	O
in	O
degree	O
of	O
pain	O
relief	O

